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Staphylococcus aureus is a major human pathogen that causes lethal systemic 
conditions such as infective endocarditis, osteomyelitis, sepsis and pneumonia. Chronic 
in nature, these diseases are often refractory to the antibiotic treatment. Such recalcitrance 
is mainly caused due to the presence of persister cells, which are a bacterial 
subpopulation that exhibits extreme, yet transient antibiotic tolerance accompanied by a 
transient halt in the growth. However, upon cessation of antibiotic treatment, resumption 
in growth of persister cells causes recurrence of infections and treatment failure, 
displaying tremendous clinical significance. In this study, we show the involvement of 
the msaABCR operon in persister cells formation in S. aureus under clinically relevant 
bactericidal antibiotics. Considering the importance of metabolism in antibiotic tolerance, 
we demonstrate causal link between cellular energy and antibiotic tolerance in S. aureus. 
We observe that the inactivation of the msaABCR operon in USA300 LAC led to 
increased tricarboxylic acid (TCA) cycle activity, cellular ATP and NADH content, and 
membrane potential. The increased ATP in the msaABCR mutant during late exponential-
phase led to decreased persister formation against different antibiotic stress, while the 
increased membrane potential in the stationary-phase led to defective persister formation 
against aminoglycoside stress. Furthermore, we show msaABCR (MsaB) as a 
transcriptional repressor of catabolite control protein E (ccpE), an activator of TCA cycle, 
and nicotinamide dehydrogenase (ndh2), the gene of electron transport chain (ETC) in S. 
aureus. 
Deletion of the msaABCR operon resulted in the downregulated expression of 
several genes involved in resistance against oxidative stress. Notably, those included 
 
iii 
carotenoid biosynthetic genes (crtM/N), OsmC/Ohr family protein (ohr) and catalase 
(katA) genes. Here, we report the transcriptional regulation of the crtOPQMN operon and 
the ohr gene by the msaABCR operon. In addition, we also show MsaB as the 
transcriptional activator of sigB (transcriptional regulator of the crtOPQMN operon) and 
transcriptional repressor of sarZ (repressor of ohr). These results suggest that the 
msaABCR operon regulates an oxidative-stress defense mechanism, which is required to 
facilitate persistent and recurrent staphylococcal infections. In conclusion, we 
demonstrate the importance of the msaABCR operon in S. aureus survival in different 
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CHAPTER I - INTRODUCTION 
1.1 Staphylococcus aureus 
Staphylococcus aureus, a gram positive, non-motile and non-spore forming 
coccoid bacterium, belongs to the phylum Firmicutes and class Bacilli. The bacterium is 
facultative anaerobe that measures 0.7-1.2 μm in diameter.  The genus Staphylococcus 
comprised of 52 species and 28 subspecies 
(https://www.bacterio.net/genus/staphylococcus), among which S. aureus is the most 
common pathogen that causes varieties of infections in human. In 1882, Ogston coined 
the term “staphylococci”, derived from Greek staphyle meaning bunch of grape, and 
kokkos meaning berry, referring to the bacterial structures as observed under microscope 
while examining the pus from a surgical abscess (1). In 1884, Rosenbach noted two 
different types of colonies: white and pigmented. S. aureus was derived from the Latin 
aurum meaning gold, referring to its characteristic golden colonies when grown on solid 
media, and S. albus for white colonies, later renamed as S. epidermidis because of its 
high prevalence on the human skin (2). In 1903, Loeb observed pronounced coagulative 
property of S. aureus when tested with the blood (3). S. aureus is now identified and 
differentiated based on coagulase positive test (ability to clot blood plasma) from other 
staphylococci species that are grouped under coagulase negative staphylococci (CNS). 
Moreover, S. aureus is positive on heat stable deoxyrobinuclease (Dnase) and the protein 
A hemagglutination tests (4). Likewise, S. aureus is catalase positive, the characteristic of 
S. aureus that produce catalase enzyme, a distinct phenomenon used to differentiate the 




The human skin microbiome constitutes the staphylococcal species including S. 
aureus.  An estimated of 30% of total human population harbors S. aureus as 
commensals on the skin surface or the anterior nares (5, 6). The successful colonization 
by S. aureus is acquired through various adhesins, surface proteins and secreted enzymes 
that withstand the lethality of antimicrobial peptides or enzymes, and lipids present on the 
human skin (7). However, loss of normal skin barrier, underlying immunocompromised 
conditions predisposes an individual to S. aureus infections.  
S. aureus is a versatile pathogen that proliferates in wide range of hosts and their 
tissues. While the optimal growth is observed under aerobic conditions, S. aureus can 
also withstand the microaerophilic conditions, which facilitates the biofilm associated 
deep seated infections (8). In response to the environmental stresses occurred during the 
course of infection, S. aureus frequently undergoes mutations in the metabolic genes that 
form distinct small colony variants (SCVs), which are known to be more persistent inside 
the host cells (9). These strategies altogether benefit the S. aureus by conferring the 
pathogen survival in the stressful host environment. 
1.1.1 S. aureus is a Public Health Burden 
S. aureus is a major bacterial pathogen that can cause remarkably diverse array of 
infections ranging from acute skin infections to systemic and often life-threatening 
conditions such as endocarditis, bacteremia, osteomyelitis and pneumonia (10). This 
versatility of the pathogen is due to the possession of plethora of virulence factors, 
acquisition of antibiotic resistance, and its ability to evade and invade the host immune 




also contributes for its prominence as an opportunistic human pathogen (13). For 
instance, S. aureus causes ~76% of all skin and soft tissue infections (14) accounting for 
10 million hospital visits annually (15).  The immunocompromised individuals with 
chronic conditions such as cancer, diabetes, vascular diseases or the patients undergoing 
treatment with medical devices such as catheters and tips are more prone to S. aureus 
infections (https://www.cdc.gov/hai/organisms/staph.html ). Indeed, the pathogen was 
previously reported to be the leading cause of health care associated (HA) infections. 
However, in the past decade, increasing emergence of community acquired (CA) S. 
aureus infections have been threatening the public health. For instance, the methicillin 
resistant S. aureus (MRSA) strain USA300 was reported to be the most common strain 
that accounted for > 98% of the emergency cases of soft tissue infections in 11 U. S. 
cities in 2004 (14). In the year 2017, Centre for Disease Control and Prevention (CDC) 
reported >119,000 MRSA associated bacteremia cases with nearly 20 thousand deaths in 
the U. S. (16). In addition, the MRSA is also reported to be the major cause of infective 
endocarditis causing ~50 thousand incidences per year with average hospital cost 
exceeding $120,000 per patient (17) and annual treatment cost of $ 4 to 30 billion in the 
US alone (14). Due to its propensity to cause severe diseases and its ability to acquire 
antibiotic resistance, S. aureus infections account for significant morbidity and mortality 
(18). Furthermore, CA-MRSA infections could act as reservoir and contribute to HA 
infections fueling the transmission both outside as well as within the health care facilities. 
Indeed, USA300 strains were emerged in the community and spread to health care 




the US and Canada, CA-MRSA has been rapidly spreading to other continents and have 
been reported from South America, Asia, Europe,  and Australia (21). Despite the 
tremendous clinical significance, there is absence of vaccination against S. aureus.  
1.2 Persister Cells 
In 1944, Bigger discovered and coined the term “persister cells” to denote a small 
fraction of S. aureus cells that could not be killed by lethal concentration of penicillin 
(22). Persister cells are a distinct phenotypic variant in the bacterial population that 
exhibits transient, yet extreme, antibiotic tolerance without undergoing any genetic 
modification (22-24).  
In In vitro experiments, persisters display a biphasic killing curve as large fraction 
of the susceptible cells are rapidly killed on exposure to high concentration of antibiotics 
while small proportion survives for extended period forming a characteristic biphasic 
killing curve (Fig. 1) (24, 25). Once the antibiotic stress is removed, persisters resume 
their growth forming a new population identical to the original population in constituting 
genetic diversity (26) and antibiotic tolerant population (27). Persister cells have been 
studied in various pathogenic microbes including S. aureus, Escherichia coli, 
Mycobacterium tuberculosis, Pseudomonas aeruginosa, Salmonella spp and Candida 
albicans (28). Due to their transient insensitivity towards antibiotic and ability to re-





Figure 1.2 Schematic illustration of antibiotic persistence 
(Killing kinetics during treatment with a bactericidal antibiotic. Maisonneuve E and Gerdes K 2014. 
Molecular mechanisms underlying bacterial persisters. Cell (25)). 
When a bacterial culture is exposed to lethal dose of bactericidal antibiotic, susceptible cells are 
killed (green line) but the tolerant persister cells survive for extended period forming a biphasic 
killing curve. The persister population shows the slower killing kinetics (red line), whereas more 
elevated slope is exhibited by the high persister (hip) mutant (dashed line). Upon removal of the 
antibiotic stress, the surviving persister cells resume growth to form new population that is 
identical to the initial population demonstrating their significance as the cause for treatment 
failures and recurring infection.  
Besides, this insensitivity towards the antibiotics benefits bacteria to adapt to a 
changing environment subsequently increases the risk of developing antibiotic resistance 
during treatment (31). In antibiotic resistance, genetic modifications in bacteria prevent 
antibiotics to act on their targets. Whereas, in antibiotic tolerance, decreased metabolic 
activity or a non- growing state of persister cells prevent the exploitation of targets by the 




1.2.1  Antibiotic tolerance is a Major Cause of Treatment Failures 
In the absence of antibiotic resistance, antibiotic-tolerant persister cells are  
believed to be largely responsible for the recalcitrance of bacterial infections leading to 
the treatment failures (33), thereby display high clinical significance. Indeed, the clinical 
importance of S. aureus persister cells has been increasingly understood, as evidenced 
by their reported presence in recurrent infections (33, 34). For instance, cases of 
bacteremia relapse, including recurring infections in endocarditis and in lung-
transplanted patients, were caused by vancomycin-, linezolid-, and daptomycin-
susceptible S. aureus (35-37). Similarly, cystic fibrosis cases of P. aeruginosa are 
frequently identified as high persister (hip) mutants (38). Moreover, the clinical 
significance of S. aureus persister cells was also demonstrated in a chronic mouse 
wound infection model, in which these cells could not be eradicated by the 
conventional drugs (39, 40).  A recent cohort study in cystic fibrosis patients detected 
the presence of non- transient hip P. aeruginosa variants that are decisive for the 
chronicity of the disease (41). Indeed, persister cells are ubiquitous and have been 
studied in multiple bacterial species (42). Antibiotic resistance occurred to be a major 
public health problem and therefore, antibiotic discovery until today are focused on 
killing the resistant bacterial cells. However, increasing evidences of treatment failures 
due to the drug sensitive persisters prompt much needed insight into eradicating an 






1.2.2 Biofilm Favors the Formation of Persister Cells That Are Difficult to Eradicate   
S. aureus is notoriously known to cause hospital device associated biofilm 
infections (43)  such as endocarditis, bacteremia, osteomyelitis, periodontitis, and chronic 
wound infections (44-48). These infections are often refractory to the antibiotic 
treatments due to the presence of persister cells (24, 49, 50). Such recalcitrance of S. 
aureus infections imposes high socio-economic burden worldwide. S. aureus biofilms are 
composed of matrix of extracellular polysaccharides, proteins and DNA from bacteria as 
well as host-derived fibrin matrices that provide niches such as low nutrient or oxygen 
level and decreased pH (51), imposing a selection pressure for the generation of 
metabolically inactive, energy depleted and antibiotic insensitive persister cells (52, 53), 
thereby causing recalcitrant infections (39, 50, 54-57). Due to their dispersal 
phenomenon, biofilm associated infections also cause metastatic infections (58, 59).  
Several approaches have been proposed to effectively kill persisters within S. 
aureus biofilms. One mechanism included the use of metabolites that enable potentiation 
of aminoglycoside leading to eradication of bacterial biofilms. For instance, addition of 
fructose and mannitol enhanced the gentamicin uptake in the bacterial cells via 
generation of proton motive force (PMF) and resulted in eradication of S. aureus and E. 
coli biofilms respectively in mouse catheter infection model (40). Likewise, L-arginine 
was also shown to facilitate biofilm eradication by gentamicin via pH mediated 
mechanism in mouse catheter model (60). Another approach in eradicating persisters in 
biofilm was demonstrated based on corruption of mechanism that is independent of the 




binds the ClpP protease resulting in degradation of more than 400 proteins.  In 
combination with rifampicin, ADEP4 was shown to eradicate persister cells in mouse 
catheter infection model (39). 
1.2.3 Mechanism of Persister Cells Formation is not Well Understood 
Despite plethora of studies and history of more than 70 years, mechanism of 
persister formation in S. aureus is poorly understood. The involvement of stringent 
response and dormancy were widely recognized as underlying factors for bacterial 
persistence, however, recent studies as challenged these findings (29, 61-63); persister 
switch has been even more an obscure bacterial phenomenon.  
Intracellular S. aureus survival is largely considered for the cause of recurrent 
infections. However, studies are lacking to understand regulation of persister switch 
intracellularly. Nonetheless, a recent study depicts a clinical relevance of treatment 
failures of S. aureus infections by demonstrating the occurrence of persister switch 
intracellularly in response to an antibiotic stress. Additionally, these persister cells were 
shown to be extremely tolerant to other antibiotics and exhibited multiple adaptive 
responses against different stresses (64). However, the regulation of the network of these 
adaptive responses is not known.  
1.2.4 Decreased Metabolism Influences Persister Cells Formation in Bacteria 
In recent years, an increasing number of studies have sought to understand the 
mechanism of persister formation dependent on the metabolic activities of bacterial cells. 
Studies have so far demonstrated an association between the depletion of intracellular 




E. coli, and P. aeruginosa (65-67).  Several studies have examined the contribution of 
metabolic genes and cellular ATP levels in the formation of S. aureus persister cells. For 
instance, Yee et al. identified the involvement of purine genes in persister cell formation 
in the presence of rifampicin (68). Likewise, Wang et al. showed that a mutant of 
succinate dehydrogenase (encoded by sdhA/B) is defective in formation of persister cells 
against an antibiotic (levofloxacin), heat, and oxidative stresses (69). Similarly, 
inactivation of phoU causes deficiency in the persister population due to increased 
metabolic activity (70). Recently, inactivation of tricarboxylic acid (TCA) cycle genes 
was shown to form drastically increased numbers of persister cells due to reduced ATP 
and membrane potential, suggesting the role of metabolism in persister formation (71, 
72). This association was also evidenced in polymicrobial cultures in which S. aureus 
displayed increased antibiotic tolerance, accompanied by reduced membrane potential 
and intracellular ATP concentration (73). The reduced ATP level associated with 
increased persister formation was also observed in inactivation of carbamoyl phosphate 
synthetase (carB) in the major pathogens S. aureus, E. coli, and P. aeruginosa (67). In 
general, it appears that the conditions that reduce intracellular ATP and membrane 
potential, as well as cease transcription or translation, dramatically increase antibiotic 
tolerance in bacteria (29, 65, 66). Together, these observations strongly suggest that the 







1.3 Oxidative Stress Response in S. aureus 
S. aureus is in a constant challenge of endogenous as well as exogenous oxidative 
stress. The incomplete reduction of oxygen during aerobic respiration leads to generation 
of reactive oxygen species (ROS) causing endogenous oxidative stress. Whereas, during 
infection, S. aureus is challenged by the exogenous oxidative stress that is exerted by the 
hostile environment (74) . Host immune cells, such as neutrophils, monocytes, and 
macrophages, express NADPH oxidase, which is responsible for generation of the 
superoxide anion (O2·−) during oxidative bursts (75), thus exerting the exogenous 
oxidative stress to the pathogen. The O2
·−  is presumed to contribute to bacterial killing 
and is involved in an array of chemical reactions that generate ROS including hydroxyl 
radicals (OH·), peroxynitrite (ONOO−), and H2O2, which are all highly lethal to bacterial 
cells (76). Killing by the host immune cells depends primarily on damaging lipids, 
proteins, and DNA of the pathogen. On the other hand, S. aureus has evolved a complex 
regulatory network that controls a multitude of defense mechanisms against the 
deleterious effects of oxidative stress stimuli.  
1.3.1 S. aureus Possess Arrays of Stress Responsive Regulators 
The defense systems in S. aureus are required for survival and persistence in its 
hosts. The acquisition of antibiotic resistance and/or tolerance and its numerous virulence 
factors contribute to the ability of S. aureus to cause variety of infections (33, 77-79). In 
addition, this pathogen has acquired the ability to evade or invade the host defense 
system to adapt and proliferate inside host immune cells during infectious processes, 




To combat these lethal effects, S. aureus has evolved complex regulatory systems. 
These systems include the characteristic golden pigment carotenoid (encoded by 
crtOPQMN) (74, 82), catalase (katA) (83, 84), and superoxide dismutases (sodA/M) (85-
87). In addition, many genes, including those of the PerR regulon (katA, mrgA, zosA, and 
ohrA) and the SigB regulon, have been shown to be involved in the response to oxidative 
stress (88, 89). S. aureus also possesses several peroxiredoxins, which are induced on 
exposure to H2O2 (90, 91). The peroxiredoxins include two enzymatic groups, the alkyl 
hydroperoxide reductase (ahpC) family and the osmotically inducible protein/organic 
hydroperoxide reductase superfamily associated with detoxification of alkyl and organic 
hydroperoxides (92). S. aureus AhpC also confers resistance to a wide spectrum of ROS 
(84).  
Since oxidative stress imparts deleterious effects to all aspects of physiology, 
including the enzymatic activity of bacterial pathogens, the regulation of defensive 
systems against these stimuli is complex (74). Alteration of enzymatic activity in turn 
changes metabolite concentrations and redox poise. These changes ultimately alter the 
activity of redox or metabolite responsive regulators such as CcpA or CodY (93, 94). The 
global regulators MgrA, SarZ, and PerR are important S. aureus proteins that are 
involved in sensing oxidative stresses (91, 95).  
Apart from these responsive systems, the environmental stimuli trigger the 
emergence of slow growing mutant population in S. aureus, known as small colony 
variants (SCVs) that are often isolated in the clinical samples. Majority of the SCVs have 




to loss of ETC, the SCV phenotypes are characteristically more resistance towards H2O2 
thus confer survival, host cell invasion and persistence causing chronic S. aureus 
infections (96). Possession of all these oxidative stress-responsive systems contributes to 
the success of S. aureus as a human pathogen capable of causing persistent infections.  
1.4 The msaABCR Operon in S. aureus 
The msaABCR operon constitutes four-genes (msaA, msaB, msaC and anti-sense 
msaR), which was previously characterized by Elasri research group  (97). Among these 
genes, msaB that encodes MsaB (also known as CspA) is the only protein coding gene 
found so far. On the other hand, the msaC, a non-protein coding RNA is found to be 
essential to regulate the function of the msaABCR operon.  In addition, the anti-sense 
msaR, which is complementary to the 5’end of the msaB, expresses differentially 
dependent on S. aureus growth phase indicating its possible function as a regulator of the 
operon (Fig. 2). In our previous studies, we observed involvement of msaABCR operon in 
virulence of S. aureus including biofilm development (97, 98), capsule production (99), 
and antibiotic resistance (100, 101). Results from these studies demonstrated msaABCR 





Figure 1.4 Schematic representation of the msaABCR Operon 
(Map of the msaABCR operon: Sahukhal GS and Elasri MO. 2014. Identification and characterization of an 
operon, msaABCR that controls virulence and biofilm development in Staphylococcus aureus. BMC 
Microbiology (97)). 
Long thin arrows with nucleotides (nt) length represent the corresponding RNAs in the operon identified by 
rapid amplification of cDNA ends (RACE) and Northern blot analysis. Short thick arrows indicate the 
positions and directions of the gene-specific primers used in the separate reactions.  
We identified that the msaABCR operon controls the processing of major 
autolysin, Atl by repressing the protease production. Inactivation of the msaABCR led to 
increased protease production causing increased processing of Atl and uncontrolled cell 
death (autolysis) resulting in defective biofilm in S. aureus (98). In another study, we 
identified the msaABCR (MsaB) essential for capsule production in two most significant 
capsule serotypes of S. aureus.  As evidenced by the decreased cap transcripts and 
capsule production in the msaABCR mutants of UAMS-1 and Mu50 strains, and binding 
to the cap promoter, MsaB was identified as the DNA-binding transcriptional activator of 
cap operon (102).  The MsaB activation of cap was found to be in late and stationary 




regulation in nutrient dependent manner, we observed MsaB interaction with CodY, a 
nutrient sensing regulator in S. aureus. CodY activates the production of capsule in 
nutrient rich condition. However, as the nutrients are depleted, the conformational 
changes in CodY results in its inefficiency in binding cap promoter whereas, MsaB was 
found to bind the cap promoter and activate capsule production under these conditions 
(99). Additionally, MsaB was also found to regulate codY and ccpE suggesting its 
implication in the host-pathogen interaction during disease progression (99).  
The inactivation of msaABCR led to decreased cell wall thickness resulting into 
increased susceptibility towards vancomycin in vancomycin intermediate S. aureus 
strains (VISA) Mu 50, HIP6297 and LIM2, thus suggested that the msaABCR contributes 
to the resistance towards vancomycin in S. aureus (100).  Furthermore, we observed that 
the increased protease activity in the msaABCR mutant resulted into decreased cell wall 
cross-linking due to increased murein hydrolase activity. Additionally, the msaABCR 
operon was found to play role in the peptidoglycan synthesis as supported by 
downregulation of genes in early peptidoglycan synthesis pathway in the msaABCR 
mutant (101). In a recent implant associated study in rats, the msaABCR operon was 
found to play role in chronic osteomyelitis by regulating extracellular proteases, adhesins 
and other virulence factors (103), suggesting that the msaABCR operon is crucial in  S. 
aureus adaptation in the host.  
1.4.1 The msaABCR Operon Functions as a Global Regulator in S. aureus 
RNA transcriptomic data of the msaABCR mutant in MRSA USA300 LAC strain 




response, and virulence in S. aureus (104). A previous study has also demonstrated MsaB 
as a RNA chaperon binding to 213 mRNAs (105). In addition, deletion of MsaB causes 
differential expression of 282 functional proteins involved in carbohydrate metabolism, 
stress response, cell wall and capsule biosynthesis. These results suggest that MsaB 
possibly modulates the functions of proteins as an RNA chaperon (105). All these 
findings highlight the importance of msaABCR (MsaB) as a global regulator and a 





CHAPTER II –SIGNIFICANCE, HYPOTHESIS AND INNOVATION 
2.1 Significance 
The treatment failures of S. aureus systemic infections impose high socio-
economic burden worldwide. Chronic in nature, these infections are difficult to treat by 
the traditional drugs. Increasing evidences suggest that the antibiotic tolerant persister 
cells are the major cause for the recalcitrance of S. aureus infections. Despite more than 
70 years of history and plethora of studies, the mechanism underlying persister cells 
formation is not yet conclusive. In this study, we studied the involvement of the 
msaABCR operon in persister cells formation and stress response in S. aureus, and 
deciphered the regulatory role of the operon in these phenomena. The role of msaABCR 
in persister formation is novel and understanding this mechanism would have significant 
impact in designing novel therapeutics that consequently would help minimize the 
treatment failures of staphylococcal infections. 
2.2 Hypothesis 
Recently, studies have demonstrated the causal link of decreased cellular energy 
state and increased antibiotic tolerance in S. aureus (65, 71-73). Considering this 
association, the differential expression of genes of metabolism and stress response in the 
msaABCR mutant as compared to the wild type USA300 LAC transcriptomics led us to 
hypothesize that the msaABCR operon regulates the response against stresses exerted by 
the antibiotics or the host environment during infections. In this study, we tested these 




Specific Aim 1: Study the involvement of msaABCR operon in persister formation 
in S. aureus. The frequency of persister formation depends on the growth conditions of 
the bacterial cultures such that it increases as the cells enter to the stationary growth 
phase. Likewise, Biofilms are referred to as the favorable niche for the generation of 
extremely tolerant persister cells due to their stressful environment. Considering the 
importance of growth phase or condition in the generation of persister cells, we tested the 
persister fraction in both planktonic (exponential, mid-exponential and stationary growth 
phase) as well as in biofilms in the presence of clinically relevant of antibiotics belonging 
to different classes. Moreover, this experimental approach would also lead us to 
understand whether the role of the msaABCR operon is growth phase or stress dependent. 
Specific Aim 2. Study the msaABCR regulation of metabolism and its association 
with antibiotic tolerance in S. aureus. Given the importance of increased metabolic 
activities in reducing antibiotic tolerance, first, we tested the impact of the msaABCR 
operon in cellular energy state of S. aureus in different growth phases. Further, we 
examined the mechanism underlying regulation of metabolism by the msaABCR operon 
and its association with the antibiotic tolerance in S. aureus.  
Specific Aim 3. Study the regulatory role of the msaABCR operon in stress 
response and intracellular persistence/survival. To withstand the environmental cues, the 
pathogens must develop adaptive responses. Previous studies along with our findings 
indicate that msaABCR (MsaB) is a global modulator of gene expression (99, 104-106). 
Since the deletion of the msaABCR operon showed differential expression of the genes 




speculated that the msaABCR operon regulates the response against environmental stress 
during infection.  In this study, we specifically examined the msaABCR regulation of 
response against oxidative stress in S. aureus.   
2.3 Innovation 
Understanding the mechanism of persister cells formation has been a puzzling 
problem particularly due to their transiency and small population size. Deletion of the 
msaABCR operon resulted in diminished number of persister cells in both planktonic as 
well as biofilm growth conditions, indicating the possibility that inactivation of the 
operon overcomes treatment failure of S. aureus infections that is associated with 
antibiotic persistence/tolerance. The study model proposed in this project deciphers the 
mechanism of antibiotic as well as intracellular persistence of an important human 
pathogen S. aureus. Identification of the regulatory determinants in persister switch is an 
aspect of S. aureus infections, which is not known. This project is innovative in that it is 
exploring the role the msaABCR operon, a global regulator in S. aureus in antibiotic as 
well as intracellular persistence. The findings from this study suggested that the 
msaABCR could be a potential target to overcome the heightened issues of therapeutic 





CHAPTER III –EXPERIMENTAL APPROACHES 
3.1 Bacterial Strains and Growth Conditions 
Methicillin-resistant S. aureus (MRSA) USA300 LAC, methicillin sensitive S. 
aureus (MSSA) UAMS-1, isogenic msaABCR operon mutant (msaABCR), and 
complementation strains were used. Bacterial pre-cultures were prepared by inoculating 
cells from frozen culture into 5 ml of freshly prepared Muller Hinton Broth (MHB) or 
tryptic soy broth (TSB; Becton, Dickinson and Company, MD, USA) or chemically 
defined medium (CDM) as previously described (99). All cultures were incubated at 37°C 
with continuous shaking at 225 rpm. The stationary-phase cultures were grown for 24 h 
unless otherwise stated. E. coli strain DH5α and the restriction-deficient S. 
aureus laboratory strain RN4220 were used to move plasmid constructs into the strains of 
choice through transformation and phage transduction. 
3.2 Generation of Transposon Mutants and Complementation 
The transposon mutants used in this study were generated as previously described 
(99, 106). Briefly, a plasmid-cured derivative of LAC strain JE2 containing the 
transposon mutation within the coding regions of the corresponding genes was obtained 
from the Network on Antimicrobial Resistance in the S. aureus (NARSA) collection (Bei 
Resources). The mutation was then transduced into either USA300 LAC or UAMS-1 
strain by generalized transduction using bacteriophage φ11. The transduction of the 
mutation into the recipient strains was confirmed by amplifying the beginning and end of 
the open reading frame (ORF) of the corresponding genes, as previously described (99, 




deletion in the strains USA300 LAC and UAMS-1, as previously described (32, 44). For 
trans-complementation, the ORF of msaABCR region was cloned into the pCN34 low-
copy-number vector with the modification of changing the kanamycin selectable marker 
to a chloramphenicol resistance marker.  
3.3 Persister Assays 
3.3.1 Persister Assays in Planktonic Cells 
Frozen S. aureus cells were inoculated in fresh MHB or TSB and grown for ~3 
hours. These pre-cultures were normalized to an OD600 nm of 0.05 in 5 ml TSB at a flask-
to-medium ratio of 10:1 and incubated at 37°C until the required growth phase: 
Exponential (OD600 nm of 0.5-0.7), mid-exponential (OD600 nm of ~4.0) and stationary-
phase (16 or 24 h). For persister measurement in exponential growth phase, first, 100 μl 
of culture in MHB was removed, serially diluted in 900 μl of 1 × phosphate buffer saline 
(PBS) and plated for colony forming units (CFUs) for the initial count. The remaining 
cultures were individually challenged with daptomycin (10 μg/ml, 10 × MIC) 
supplemented with 50 mM calcium chloride (CaCl2), vancomycin (25 μg/ml, 40 × MIC), 
linezolid (50 μg/ml, 10 × MIC), rifampicin (2.4 μg/ml, 40 × MIC), and gentamicin 
(20 μg/ml, 20 × MIC) and further incubated at 37 °C with continuous shaking. We used 
the minimum concentration of each antibiotic that showed similar killing kinetics to that 
of higher concentrations of the respective antibiotic. At designated time points of 
antibiotic exposure, 100-μl of aliquot was removed, washed with 900 μl of 1× PBS and 
plated for the CFUs count after 24 h of incubation. When the culture reached stationary-




culture was challenged with antibiotics daptomycin (80 μg/ml, 80 × MIC) with 50 mM 
CaCl2, vancomycin (125 μg/ml, 200 × MIC), linezolid (100 μg/ml, 20 × MIC), rifampicin 
(4.8 μg/ml, 80 × MIC), gentamicin (20 μg/ml, 20 × MIC) and tobramycin (20 μg/ml, 20 × 
MIC). Likewise, to measure the persister frequency in mid-exponential phase, first, 100-
μl aliquots were diluted in PBS and plated for the initial CFU counting, whereas 3 ml of 
the culture was individually challenged with gentamicin (20 μg/ml, 20 × MIC), 
vancomycin (62.5 μg/ml, 100 × MIC), ciprofloxacin (250 μg/ml, 100 × MIC), or 
tobramycin (20 μg/ml, 20 × MIC) and incubated further. At the designated time post 
exposure, 100 μl of culture was removed, washed with PBS, diluted, and plated for CFU 
counting. 
For the persister assay in the presence of arsenate and carbonyl cyanide m-
chlorophenyl hydrazone (CCCP), stationary-phase cells were challenged with arsenate (1 
mM) and different concentrations of CCCP (0.001–10 μM) for 30 min prior to the 
addition of gentamicin. At 24 h post exposure, the cells from 100-μl aliquot were 
harvested, washed, and plated for CFU counting.  
3.3.2 Persister Assays on Catheter Based Biofilms 
To measure persister in catheter based biofilms, 1-cm-long sterile catheters 
(fluorinated ethylene propylene, BD Infusion Therapy System Inc., UT) were incubated 
with 20% human plasma (Sigma-Aldrich, MO) overnight in 24-well microtiter plates. 
After plasma coating, the catheters were incubated with S. aureus cells (OD600 of 0.05) in 
biofilm medium (TSB + 0.5% glucose + 3% NaCl) for 24 h with continuous shaking. 




non-adherent S. aureus cells, and sonicated for initial CFU counting. The remaining 
catheters were treated with antibiotics and further incubated at 37°C. Each day after 
treatment, the catheters (n=3) were recovered, and the spent medium was replaced with 
fresh biofilm medium (500 μl) with the corresponding antibiotics. The catheters were 
gently rinsed in PBS to remove any non-adherent bacteria, placed in glass tubes, and 
sonicated to recover the adherent S. aureus cells. The recovered CFUs were counted for 
all three catheters. This procedure was continued for 4 days. All experiments were 
performed in triplicate and repeated twice.  
3.4 RNA Extraction, Reverse Transcription, and qRT-PCR 
Aliquots of 500 μl from the required growth cultures were treated with equal 
volumes of RNAprotect bacterial reagent (Qiagen, Valencia, CA) for 5 min at room 
temperature. Total RNA was extracted using the Qiagen RNeasy kit (Qiagen), and the 
quality and concentration of the extracted RNA were analyzed using a NanoDrop 
spectrophotometer (Thermo Scientific). Reverse transcription was performed with the 
iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA) using 1 μg of the total 
RNA isolated according to the manufacturer’s instruction. Next, qRT-PCR was 
performed using SYBR Green supermix (Bio-Rad), and the relative fold change in gene 
expression was calculated using gyrB as an endogenous control gene. The data represent 







3.5 Measurement of ATP 
Intracellular ATP content was measured using the BacTiter-Glo™ kit (Promega, 
WI, USA) according to the manufacturer’s instruction. Briefly, cells grown to the 
required phase were adjusted to an OD600 nm of 0.025 in 1 ml of TSB, from which 50 μl 
were dispensed into wells of an opaque 96-well plate, followed by the addition of an 
equal volume of BacTiter-Glo™ Reagent. The luminescence was measured at OD560 nm 
after 5 min of incubation at room temperature. 
3.6 Measurement of NAD+/NADH Content 
Overnight cultures were diluted to an OD600 of 0.05 and grown until late 
exponential-phase (OD600 of 4.0). Cells were harvested and washed twice with ice-cold 
PBS, and NADH levels were measured according to the manufacturer’s instructions 
(NAD+/NADH quantitation kit, Sigma-Aldrich). Values represent the absolute 
concentrations of NAD+ and NADH per μg of protein.  
3.7 Measurement of Membrane Potential 
Membrane potential was assessed using the BacLight™ Bacterial Membrane 
Potential kit (Life Technologies, USA). Stationary-phase cells were washed and 
resuspended with 0.5 ml of filtered PBS (2 × 107 cells). Next, 16.6 µl of the fluorescent 
membrane potential indicator dye 3, 3′-diethyloxacarbocyanine iodide (DiOC2(3)) was 
added and incubated at room temperature for 30 min. The fluorescent signals of 100,000 
cells were recorded using a Fortressa flow cytometer (BD Biosciences, CA, USA). 




DiOC2(3). The ratio between red fluorescence (PE-A) and green fluorescence (FITC) was 
calculated and analyzed with FlowJo v10 software.  
3.8 Expression and Purification of MsaB 
The MsaB protein was expressed in msaABCR mutant of USA300 LAC strain. 
The primers UpA, UpB, DnC, and DnD listed in Table 4.13 were used to label MsaB 
protein with 6 × His at the C-terminal end (MsaB-His). To generate the expression 
construct, the ORF of msaB was PCR amplified using primers listed in Table 4.13 and 
cloned into the inducible plasmid pCN51using the BamHI and EcoRI restriction 
enzymes. The plasmid construct was then transformed into E. coli strain DH5α. The 
plasmid isolated from transformed DH5α cells was used to transduce the restriction-less 
S. aureus RN4220 competent cells. The plasmid was then moved to USA300 LAC 
msaABCR mutant through generalized transduction using bacteriophage φ11.Protein 
expression was induced by adding 10 μM cadmium chloride (CdCl2) at exponential-phase 
and incubating further with shaking. The cells were pelleted after 4 h of induction, 
resuspended in PBS (pH 7.4) with a protease inhibitor cocktail, and then lysed by bead 
beating followed by sonication. The cell lysate was centrifuged at 10,000 × g for 30 min 
to remove the cell debris. The 6 × His-MsaB fusion protein was purified from the clear 
lysate with a nickel column (HisPur Ni-nitrilotriacetic acid [Ni-NTA] resin; Thermo 
Scientific).  
3.9 Chromatin Immunoprecipitation (ChIP) Assay 
The ChIP assay was performed as described by Sengupta et al. (108), with slight 




were treated with 1% formaldehyde and 10 mM sodium phosphate to facilitate the cross-
linking of MsaB to its targets. After 20 min, the cross-linking reaction was quenched by 
the addition of 0.1 volumes of 3 M   glycine. The cultures were then pelleted and washed 
with an equal volume of 0.1 M phosphate buffer to remove excess formaldehyde. The 
phosphate buffer was removed by centrifugation, and the cells were resuspended in 
600 μl IP buffer (50  mM Tris/HCl pH 7.5, 150  mM NaCl, 1  mM EDTA, 1  mM PMSF, 5 
% (v/v) glycerol, 1% Triton X-100) and lysed with a bead beater. The 400-μl cell lysates 
were then sheared by sonication to obtain fragment sizes of ~500 bp. The clear 
supernatant obtained after brief centrifugation was diluted with 1 ml IP buffer, and an 
anti-MsaB antibody (diluted 1: 1000) was added and incubated at room temperature for 2 
h with gentle shaking. This antigen–antibody mixture was then added to prewashed 
protein G-coupled magnetic beads (Thermo Scientific) and incubated further for 1 h as 
above. The antigen–antibody–bead complex was collected with a magnetic tube holder, 
washed five times with wash buffer (Tris-buffered saline, 0.05 % Tween 20, 0.5 M 
NaCl), followed by washing once with ultrapure water. The beads were then resuspended 
in 100 μl elution buffer (0.1 mM glycine, pH 2.0) and neutralized with neutralization 
buffer (Tris-EDTA, pH 8.0), followed by incubation at 65 °C overnight to reverse the 
cross-links (decoupling). The DNA extracted with the phenol–chloroform extraction 
method was used as the template to detect the MsaB-bound promoter sequences with 
PCR amplification using promoter-specific primers. The msaABCR mutant was used as 
an internal negative control to demonstrate that the MsaB antibody is specifically 




3.10 Electrophoretic Mobility Shift Assay (EMSA) 
Electrophoretic mobility shift assays were performed using the LightShift™ 
optimization and control kit (Thermo Scientific) according to the manufacturer's protocol. 
Briefly, the binding reaction mixture was prepared with ultrapure water containing 1× 
binding buffer, 50 ng poly (dI-dC), 2.5% (v/v) glycerol, 0.05% (v/v) NP-40, and 5 mM 
MgCl2. Biotin-labeled probes for ndh2, ccpE and gudB genes (listed in Table 4.13) in the 
appropriate concentrations were incubated with increasing concentrations of purified 
recombinant MsaB–His protein in the binding reaction buffer and unlabeled specific 
probe when required. The mixture was then incubated at room temperature for 25 min 
and subjected to electrophoresis at 100 V for 1 h in a pre-run 5% Tris-borate EDTA 
(TBE) gel. The samples were then transferred to a nylon membrane, incubated for 45 min 
in the cold, crosslinked, and processed for the detection of samples. The protein–DNA 
complexes in the gel were then visualized using the Chemiluminescent EMSA kit 
(Thermo Scientific) according to the manufacturer's protocol and imaged with a 
ChemiDoc system (Bio-Rad). Probes used in this assay are listed in Table 4.13. 
3.11 Gentamicin Uptake Assay 
Gentamicin–Texas Red conjugate (Gent :: TR) was prepared as previously 
described (109) with slight modifications. Briefly, 440 µl of 50 mg/ml gentamicin sulfate 
was mixed with 60 µl of 2 mg/ml amine-reactive Texas Red-X succinimidyl ester 
(Invitrogen) in anhydrous N, N-dimethylformamide. The mixture was gently rotated for 3 
days at 4°C to produce an approximately 30: 1 molar ratio (~10 mM gentamicin and 0.3 




stationary-phase cells (2 × 107), washed, and resuspended in 2 ml PBS for 3 h at 37°C 
with continuous rotation. After incubation, the cells were washed twice, resuspended in 
500 μl PBS, and evaluated by flow cytometry with excitation/emission maxima at 
595/615 nm.  
3.12 In vitro Oxidative Stress Assays 
The stationary-phase cells prepared as above were washed, and diluted to an 
OD600 nm of 0.1 in 1 ml PBS and containing 34 mM H2O2 and incubated for 1 h. After 
incubation, catalase (2,000 U/ml) was added and incubated for 1 min at room temperature 
to decompose the remaining H2O2. The cells were diluted and plated to obtain the CFUs 
count. The survival percentage represents the percentage of initial CFUs that survived the 
H2O2 treatment after 1 h. Similarly, the cells prepared as described above were stressed 
with 25 mM H2O2 in 5 ml of TSB, and growth was monitored by CFUs count at 
designated time points. A detection limit of 100 CFU/ml was established for the results 
that showed ≤102/ml in undiluted culture treated with H2O2. For organic hydroperoxide 
assays, cells were prepared as described above, washed with PBS, and diluted to an 
OD600 of 6.0 for all strains tested. The cells were then serially diluted (up to 10
–8), and 10 
μl of each dilution was pipetted onto tryptic soy agar (TSA) plates containing 5 mM tert-
butyl hydrogen peroxide (tBOOH) and 4 mM cumene hydrogen peroxide (CHP) to obtain 
the CFUs count after 24 h incubation. 
3.13 Construction of Fsmut-msaB 
We used an overlap extension PCR cloning technique to generate a frameshift 




amplified by using primer set Fsmut-msaB F1 and Fsmut-msaB R1, and the lower 1,090-
bp fragment of msaABCR operon region was amplified using primer set Fsmut-msaB F2 
and Fsmut-msaB R2. Primers Fsmut-msaB R1 and Fsmut-msaB F2 overlap, such that an 
insertion of one nucleotide causes a frameshift mutation in msaB. Both the PCR 
fragments were PCR purified using a Promega DNA cleanup kit, and 50 ng of each 
fragment was used in the PCR ligation, which contained all the ingredients of the PCR 
mix except the terminal primers (Fsmut-msaB F1 and Fsmut-msaB R2). The PCR cycle 
was carried out for 15 cycles, and finally, the terminal primers were added to the reaction 
mixture and PCR was run for 20 additional cycles. The amplified PCR product was 
ligated with the pCN34 low-copy-number plasmid vector, and then transduced into the 
msaABCR mutant using bacteriophage φ11. The FSmut-msaB construct was verified by 
sequencing. Primers used in this experiment are listed in Table 4.13. 
3.14 Overexpression of the ohr Gene 
To generate the overexpression construct, the ohr gene was PCR amplified using 
primers listed in Table 4.13, and cloned into the inducible plasmid pCN51 using the 
BamHI and EcoRI restriction enzymes. The plasmid construct was then transformed into 
E. coli strain DH5α. The plasmid was then isolated from transformed DH5α cells and 
used to transduce the restriction-less S. aureus RN4220 competent cells. The plasmid was 
moved to the msaABCR mutants (msaABCR :: POhr) through generalized transduction 
using bacteriophage ϕ11, as described previously (100). The overexpression of the gene 
was analyzed with qRT-PCR by adding CdCl2 (10 nM to 1 μM) in the exponential growth 




10-fold, while use of different concentration (higher or lower), the expression level of ohr 
was lowered. Therefore, we chose this concentration for the induction. When preparing 
msaABCR :: POhr cells for the oxidative stress assay, cells were induced by adding 
100 nM CdCl2 in the early (2 h), late and post-exponential (4 h and 12 h) growth phases 
of culture. 
3.15 Extraction of Staphyloxanthin 
Staphyloxanthin (STX) was extracted using the methanol extraction method as 
described previously (97). Briefly, cells grown overnight were normalized to an OD600 of 
0.05 in 10 ml of TSB and cultured for 16 h at 37°C with continuous shaking. Cells were 
harvested, washed twice with deionized water, and pelleted after normalizing all the 
strains to an OD600 of 10.0 in 1 ml. Then, the cells were mixed with 1 ml of methanol and 
incubated in a 58°C water bath for 10 min with occasional vortexing. The supernatant 
was harvested by centrifugation at 16,000 × g for 1 min, and the absorbance of STX was 
measured at OD465, with methanol as a blank.  
3.16 Macrophage Survival Assay 
Macrophages (RAW 264.7) were prepared by growing in Cyto 6-well plates in 
sterile RPMI 1640 medium at 37°C supplemented with CO2. Stationary-phase S. aureus 
cells were harvested, washed, and diluted in PBS. The bacterial cells (2 × 105 CFUs) with 
a multiplicity of infection (MOI) of 10 were incubated with macrophages at 37°C 
supplemented with CO2. At a designated time, gentamicin 200 μg/ml was added to each 
well for 20 min to kill extracellular bacterial cells. The content of each well was gently 




added to rupture the macrophages. The released bacterial cells were serially diluted and 
plated on Columbia agar to determine the intracellularly surviving CFUs count after 
incubation at 37°C for 24 h. 
3.17 In vitro Whole-Blood and Neutrophil Survival Assay 
The survival of S. aureus in whole human blood was measured in vitro. In brief, 
heparinized venous blood samples were collected from healthy donors according to a 
protocol approved by the Institutional Review Board (IRB) for Human Subjects at the 
University of Southern Mississippi. S. aureus cells were harvested in the post 
exponential-phase of growth. The blood samples (3 ml) were inoculated with 3 ×105 S. 
aureus cells in a 14-ml culture tube and incubated at 37°C for 2 h with end-over-end 
rotation at 20 rpm. The samples were then diluted with sterile deionized water to lyse the 
blood cells, and the number of CFU was determined after plating on TSA plates. The 
neutrophil survival of S. aureus was measured using freshly isolated human polymorphic 
neutrophils (PMNs). In brief, PMNs (1×106) were combined with S. aureus (1×107) in a 
24-well tissue culture plate and centrifuged at 380 × g for 8 min. The CFUs were then 
incubated for 2 h at 37°C with 5 % CO2. After incubating, the neutrophils were lysed 
using deionized water, plated on TSA plates, and incubated overnight at 37°C. The CFUs 
were counted, and the test samples were compared with controls, which contained 
deionized water instead of the neutrophil suspension. This assay measures the total 






3.18 Statistical Analysis 
All data were analyzed using OriginPro (2017) software using student’s t-test 
(unpaired) or one-way analysis of variance (ANOVA) followed by Tukey’s multiple 





CHAPTER IV –RESULTS 
4.1 The msaABCR Mutant Exhibits Similar Growth Kinetics and the Antibiotic 
Susceptibility as Wild Type USA300 LAC 
Prior to conducting persister assays, we examined the growth kinetics, and MIC 
values of our test strains (wild type USA300 LAC, isogenic msaABCR mutant and its 
complementation). In the nutrient rich medium MHB or TSB, there was no observable 
growth defect in the msaABCR deletion mutant in both exponential and stationary growth 
phase as compared to the wild type USA300 LAC (Fig. 4.1A, B).  
 
Figure 4.1 Measurements of growth kinetics 
(A) Growth rate measurement in nutrient rich MHB medium during the exponential-phase of growth. (B) 
Growth rate in the stationary-phase of growth. Data represents the number of CFUs at the designated time 
points. Error bars represent standard error (SE). 
Considering the clinical significance of antibiotic tolerance, in this study, we 
measured the persister frequency against antibiotics daptomycin, vancomycin, linezolid, 
rifampicin and gentamicin that are commonly used to treat serious MRSA infections as 












America (110). To determine the MIC values of these antibiotics, standard micro-broth 
dilution method was followed and their susceptibility was defined based on the Clinical 
Laboratory and Standards Institute (CLSI) guidelines (111). Deletion of the msaABCR 
operon did not change the susceptibility of S. aureus towards daptomycin, linezolid, or 
gentamicin. Whereas, it showed two-fold decrease in MIC values of rifampicin and 
vancomycin as compared to the wild type USA300 LAC (Table 4.1).  
 Determination of minimum inhibitory concentration (MIC) values of antibiotics 
Antibiotics 
Minimum Inhibitory Concentration (μg/ml) 
USA300 LAC msaABCR  Complementation 
Daptomycin 1 1 1 
Rifampicin 0.06 0.0312 0.06 
Vancomycin 0.625 0.312 0.625 
Linezolid 5 5 5 
Gentamicin 1 1 1 
Tobramycin 1 1 1 
Ciprofloxacin 2.5 2.5 2.5 
 
These selection criteria including similar growth rate, and susceptibility of our test 
strains, ruled out the possibility that the growth defects or the increased drug resistance 
were responsible for the corresponding persister frequency in our test strains.  
4.2 Role of the msaABCR Operon in Persister Cells Formation 
During exponential growth of bacteria, persisters are developed at low 
frequencies, which increase drastically upon entering the stationary growth phase (24, 32, 
65). Indeed, almost all stationary-phase S. aureus cells are tolerant towards the 
conventional drugs, behaving as persister cells because of their characteristic slow- and 




population due to their stressful environment resulting through depletion of nutrients and 
oxygen level (50, 52). Therefore, in this study, first, we sought to examine whether the 
impact of the msaABCR operon in persister cell formation is dependent on growth phases 
or conditions (exponential, stationary, and biofilm) and the antibiotic stress. In these 
assays, we observed different trajectories of killing curves corresponding to the antibiotic 
treatment and the growth conditions of our test strains. To confirm whether the surviving 
cells were persister cells, first, we conducted retreatment experiment in which the 
persister cells grown in fresh medium were exposed to the antibiotic for four consecutive 
cycles. These successive exposures resulted in similar trajectories and frequencies of 
surviving population confirming that the surviving cells were the persister cells rather 
than the resistant cells (Fig. 4.2). 
 
Figure 4.2 Re-treatment assays 
The persister cells retrieved from the vancomycin exposure were grown in fresh MHB medium and treated 
with vancomycin, and the persister population was measured in designated time points. This experiment 
was repeated consecutively for four cycles. Values represent the results from three independent 
experiments. Student’s t-test was used to compare the results of the mutant to wild type strain at 










4.2.1 Inactivation of the msaABCR Operon Decreases Persister Cells Formation in 
the Exponential Growth Phase 
The msaABCR mutant was defective in persister cells in most of the antibiotics 
tested during the exponential-phase. Daptomycin rapidly killed majority of all the cells 
tested within 2 h of treatment. The persister plateau was observed in USA300 LAC and 
the complementation strains after 6 h post treatment till 24 h, however no visible CFUs 
were detected in the msaABCR mutant post 2 h treatment, demonstrating a failure of 
persister formation by the msaABCR mutant in the presence of daptomycin (Fig. 4.2.1B).  
Likewise, the number of persister cells in the msaABCR mutant was decreased by 
23-fold relative to the wild type USA300 LAC within 48 h of vancomycin treatment 
while 55-fold reduced persister cells were observed with rifampicin treatment for 16 h 
(Fig. 4.2.1C, E). But, the msaABCR mutant formed similar proportion of persister cells as 
that of wild type on exposure to linezolid for upto 72 h (Fig. 4.2.1D). Whereas, 
gentamicin showed the highest killing rate forming a persister plateau from 2 to 6 h post 
exposure, with 12.5-fold reduced persister cells in the msaABCR mutant compared to 






Figure 4.2.1 Persister assay in the exponential growth phase 
Exponentially grown cells were exposed to the antibiotics and persister population was measured at 
designated time points. (A) No antibiotic control. (B) Daptomycin (10 μg/ml, 10 × MIC) treatment. 
(C) Vancomycin (25 μg/ml, 40 × MIC) treatment. (D) Linezolid (50 μg/ml, 10 × MIC) 
treatment. (E) Rifampicin (2.4 μg/ml, 40 × MIC) treatment.  (F)  Gentamicin (20 μg/ml, 20 × MIC) 
treatment. Persister population was measured at designated time points post antibiotic exposure. Time 0 h 
represents the antibiotic exposure initiation point. The results represent the means of three independent 
experiments. Error bars represent SE. Student’s t-test was used to compare the results of the msaABCR 



































4.2.2 Stationary-Phase msaABCR Mutant is Defective in Persister Cells Formation 
in Gentamicin Stress 
In the stationary growth phase, daptomycin although killed fraction of cells, there 
was no observable difference in the persister population between the wild type and the 
msaABCR mutant (Fig 4.2.2B).  
 
Figure 4.2.2 Persister assay in the stationary growth phase 
S. aureus cells grown for 16 h in MHB were exposed to the antibiotics and persister population was 
measured at designated time points. (A) No antibiotic control. (B) Daptomycin (80 × MIC) treatment. (C) 
Vancomycin (200 × MIC) treatment. (D) Linezolid (20 × MIC) treatment. (E) Rifampicin (80 × MIC) 
treatment. (F) Gentamicin (25 × MIC) treatment. The results represent the means of three independent 
experiments. Error bars represent SE. Student’s t-test was used to compare the results of the wild type to 



































Likewise, we observed similar extent of tolerance towards vancomycin, and 
rifampicin in both strains (Fig. 4.2.2C, E). In contrary, the stationary-phase msaABCR 
mutant formed 44.67-fold less persister cells relative to USA300 LAC at 72 h post 
exposure with linezolid (Fig. 4.2.2D). Interestingly, gentamicin rapidly killed stationary-
phase msaABCR mutant cells within 12 h post treatment, resulting into 1.72 ×104-fold 
reduced persister cells relative to USA300 LAC. While, no detectable CFUs were 
observed in the msaABCR mutant after 24 h, ~5 log CFUs were observed in the wild type 
until 48 h post gentamicin treatment (Fig. 4.2.2F).  
4.2.3 The Role of the msaABCR in Tolerance towards Aminoglycoside is Specific 
and Independent of the S. aureus Strains 
To further confirm the necessity of the msaABCR operon in tolerance towards 
aminoglycoside stress in the stationary-phase, we measured the persister frequency in 
24 h cultures in TSB in the presence of gentamicin. In this assay too, the msaABCR 
mutant failed to form persisters, while a fraction of persisters was detected in the 
USA300 LAC and complementation strains for a prolonged period, displaying biphasic 
Killing curves (Fig. 4.2.3.1A, B). We also measured the persister fraction in the presence 
of another aminoglycoside antibiotic, tobramycin, in stationary-phase and biofilm growth 
conditions. Again, under both growth conditions, the msaABCR mutant formed 
significantly fewer persister cells than the USA300 LAC and complementation strains 






Figure 4.2.3.1 Measurement of persister fraction in the presence of aminoglycosides  
(A, C, and E) The killing of USA300 LAC, isogenic msaABCR mutant, and complementation cells in the 
presence of antibiotics at the indicated time points. Strains grown to stationary-phase in TSB were exposed 
to gentamicin (20 × MIC) and tobramycin (20 × MIC) and biofilms to tobramycin (20 × MIC). (B, D, and 
F) Bar graph showing the percentage survival of all test strains at the endpoint of each treatment. (A and B) 
Gentamicin treatment. (C and D) Tobramycin treatment in stationary-phase culture. (E and F) Tobramycin 
treatment on catheter biofilms. Error bars indicate standard error of the mean (SEM) of at least three 
independent experiments. Statistical significance was determined using ANOVA followed by Tukey’s 





Figure 4.2.3.2 Antibiotic stress and strain dependent role of the msaABCR in persister 
formation 
(A and B) The killing of stationary-phase USA300 LAC, isogenic msaABCR mutant, and complementation 
cells in the presence of antibiotics at the indicated time points. Strains grown to stationary-phase in TSB 
were exposed to antibiotics. (A) Vancomycin (200 × MIC) treatment. (B) Ciprofloxacin (200 × MIC) 
treatment. (C) The killing of standardized stationary state UAMS-1, isogenic msaABCR mutant and the 
complementation cells in the presence of gentamicin (20 × MIC). (D) Bar graph showing the percentage 
survival at the endpoint of gentamicin treatment. Error bars indicate SEM of at least three independent 
experiments. Statistical significance was determined using ANOVA followed by Tukey’s multiple 
comparison tests. **, P < 0.001. 
By contrast, the stationary-phase msaABCR mutant and USA300 LAC strains 
formed similar fractions of persister cells in the presence of vancomycin and 
ciprofloxacin (Fig. 4.2.3.2A, B), suggesting that the role of the msaABCR in persister 




msaABCR operon is strain dependent, we further examined the persister fraction MSSA 
strain UAMS-1. In this strain background too, the msaABCR mutant formed decreased 
persister cells indicating that the involvement of the msaABCR operon in aminoglycoside 
tolerance is independent of the S. aureus strain (Fig. 4.2.3.2C, D).  
4.2.4 The Biofilms of msaABCR Mutant Exhibits Decreased Persister Tolerance 
Biofilms provide the source of extremely tolerant persister cells (24, 33, 39, 52). 
In our previous study, although early stages (attachment and accumulation) of biofilm 
were observed to a similar extent, mature biofilm of the msaABCR mutant was 
substantially weaker and loose in comparison to the robust biofilm of the wild type 
USA300 LAC (98). Therefore, we speculated less persister cells formation in the biofilms 
of msaABCR mutant. To test this, we measured the rate of persister cells formation in 
intravenous catheter based biofilm conditions. First, we assessed the biofilm formation by 
USA300 LAC, msaABCR deletion mutant and the complementation strains on the 
intravenous catheters for four days without antibiotic treatment. We observed that 
the msaABCR mutant formed 2.3-fold reduced biofilm (2.13 × 108 CFUs) relative to the 
USA300 LAC (4.89 × 108 CFUs) (Fig. 4.2.4A). When challenged with the antibiotics, we 
observed pronounced biphasic killing curves in all strains, except for rifampicin, in which 
the S. aureus cells showed adaptive resistance after one day post exposure of rifampicin 
(Fig. 4.2.4D). The biofilms of msaABCR mutant formed significantly less persister cells 
in the presence of daptomycin, linezolid, and vancomycin. Interestingly, the biofilms of 
msaABCR mutant was eradicated by gentamicin within day 2, while the wild type 





Figure 4.2.4 Persister assay in biofilms 
Biofilms formed on intravenous catheters for 24 h were exposed to the antibiotics and persister population 
was measured at designated time points. (A) No antibiotic control. (B) Daptomycin (20 × MIC) treatment. 
(C) Vancomycin (20 × MIC) treatment. (D) Rifampicin (80 × MIC) treatment. (E) Linezolid (20 × MIC) 
treatment. (F) Gentamicin (20 × MIC) treatment. The results represent the means of three independent 
experiments. Error bars represent SE. Student’s t-test and one way ANOVA followed by Tukey’s test was 





































4.3 The msaABCR Mutant Shows Increased Expression of TCA Cycle Genes, 
Higher ATP and NADH Content 
Persister cell formation in a growing staphylococcal population is associated with 
low cellular energy levels (65-67), accompanied by low levels of expression of TCA 
enzymes (72). Therefore, we hypothesized that the deletion of the msaABCR operon in S. 
aureus cells would result in increased metabolic activity, thus inducing a higher energy 
state that prevents persister cell formation. To test this prediction, we first measured the 
expression of TCA genes and ATP levels in our test strains. In S. aureus, the TCA cycle 
is activated during late exponential growth phase to generate ATP when glucose is 
exhausted (112, 113). We examined TCA cycle activity by measuring the expression of 
TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B, and fumC) in late exponential growth 
phase via quantitative real-time PCR (qRT-PCR). As expected, we found transcriptional 
upregulation of all the TCA genes in the msaABCR mutant compared with the USA300 
LAC strain (Fig. 4.3A).   Likewise, the msaABCR mutant exhibited higher ATP levels 
relative to the USA300 LAC strain in the late-exponential growth phase (4.3B) and 
stationary growth phase (Fig. 4.3C). Considering that the TCA cycle provides reduced 
dinucleotides, we measured NADH content in our strains, and the results showed 
significantly higher NADH content in the msaABCR mutant than in the USA300 LAC 









Figure 4.3 Measurement of TCA cycle activity, intracellular ATP and NAD+/NADH 
content 
(A) Fold change expression of TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B, and fumC) in late 
exponential growth phase for the msaABCR mutant compared with the USA300 LAC strain, as measured 
by qRT-PCR. (B) The ATP concentrations per CFU of all strains were measured in late exponential and 
(C) stationary growth phases. The data represent the average of three ATP concentrations per CFU for each 
individual sample measured with two biological replicates. (D) Absolute concentration of NAD+/NADH 
content in all strains grown to late exponential-phase. Error bars represent the SEM of the three 
independent experiments. Statistical significance was determined using analysis of variance (ANOVA) 







4.4 Decreased Number of Persister Cells Form in the msaABCR Mutant During 
Late Exponential-Phase 
Since we observed increased TCA cycle activity and intracellular ATP level in the 
msaABCR mutant, we hypothesized that this increased energy level would lead to 
decreased persister formation. To test this prediction, we first measured the persister 
fraction in late exponential growth phase in the presence of antibiotics targeting protein 
synthesis (gentamicin), cell wall synthesis (vancomycin), and replication (ciprofloxacin). 
Similar as of stationary-phase, in this phase of growth too, the msaABCR mutant was 
eradicated by gentamicin after 24 h, whereas a fraction of USA300 LAC and 
complementation strains showed prolonged survival for up to 48 h, with corresponding 
biphasic killing curves (Fig. 4.4A, B).  
Likewise, the msaABCR mutant showed significantly fewer persister cells than 
the USA300 LAC and complementation strains when treated with vancomycin and 
ciprofloxacin (Fig. 4.4C–F). Interestingly, all the test strains showed a higher fraction of 












Figure 4.4 The msaABCR mutant exhibits less antibiotic tolerance in the late 
exponential-phase  
(A, C, and E) The killing of USA300 LAC, isogenic msaABCR mutant, and complementation cells in the 
presence of antibiotics at the indicated times. All strains were grown in TSB to late exponential growth 
phase (OD600 nm of 4.0) and exposed to gentamycin (20 × MIC), vancomycin (100 × MIC), or 
ciprofloxacin (100 × MIC). (B, D, and F) Bar graph showing the percentage survival of all strains measured 
at the endpoint of each treatment. (A and B) Gentamycin treatment. (C and D) Vancomycin treatment. (E 
and F) Ciprofloxacin treatment. Error bars represent the standard SEM from three independent 
experiments. Statistical significance was determined using ANOVA followed by Tukey’s multiple 





4.4.1 Increased Antibiotic Tolerance Corresponds with the Decreased Energy Level 
in S. aureus Cells 
The killing efficiency of all the bactericidal antibiotics depends on the cellular 
energy level. Therefore, target inactivation due to a low-energy state should cause 
increased tolerance to antibiotics in stationary-phase bacterial cells (24, 58). This 
proposal has been supported by several studies that reported increased persister formation 
corresponding to the depletion of ATP in different bacterial species (65, 66). These 
studies, as well as our observations in late exponential-phase, suggest a causal link 
between high intracellular ATP content and decreased persister formation in S. aureus 
cells.  
To further examine the importance of ATP in antibiotic tolerance, we measured 
the persister fraction by depleting intracellular ATP with arsenate. Arsenate is a toxic 
compound that uncouples oxidative phosphorylation subsequently producing a futile 
respiration cycle (114). Arsenate resembles phosphate such that it can bind to ADP. 
Therefore, the mechanism of the uncoupling involves the substitution of phosphate by 
arsenate resulting in the synthesis of ADP-arsenate, which undergoes non-enzymic 
hydrolyzed (115). Therefore, arsenate lowers the rate of ATP synthesis by forming 
rapidly hydrolysable ADPs. When cell cultures were pre-exposed to 1 mM arsenate, the 
intracellular ATP level was reduced, resulting in a dramatic increase in the persister level 
in the msaABCR mutant that was comparable with the USA300 LAC and 




These results together demonstrate that a high cellular energy level is necessary 
for the killing efficiency of bactericidal antibiotics and that a low energy level increases 
antibiotic tolerance in bacterial cells. 
 
Figure 4.4.1 Association between cellular ATP and persister frequency 
(A) ATP concentrations were measured at stationary growth phase in the presence and absence of 1 mM 
arsenate. The data represent the average of three ATP concentrations per CFU of each individual sample 
measured with two biological replicates. (B) Persister frequency (log10 survival fraction) was measured in 
stationary-phase culture against gentamicin (20 × MIC), with and without prior exposure to arsenate (ars.). 
The data represent the results from three independent experiments. Error bars represent the SEM. Statistical 
significance was determined using ANOVA followed by Tukey’s multiple comparison tests. **, P < 0.001; 
ns, not significant. 
4.5 The msaABCR Operon Indirectly Regulates the TCA Cycle Activity 
Since, we observed increased expression of TCA genes and ATP level in the 
msaABCR mutant; next, we sought to examine msaABCR regulation of the TCA cycle. 
The LysR-type regulator catabolite control protein (CcpE) functions as a major positive 
transcriptional regulator of aconitase, encoded by the first gene in the TCA cycle (acnA) 




expression of ccpE in late exponential growth phase. The qRT-PCR revealed 
upregulation of ccpE (>2-fold) in the msaABCR mutant compared with the USA300 LAC 
strain (Fig. 4.5A). Likewise, in the late stages of S. aureus growth, catabolism of the 
amino acid glutamate by glutamate dehydrogenase (gudB) ultimately fuels the TCA cycle 
through 2-oxoglutarate. Further, to observe the specific requirement of amino acid 
catabolism, we measured the expression of gudB in our test strains grown in chemically 
defined media (CDM) containing amino acids. The qRT-PCR result showed increased 
expression (>3-fold) of gudB in the msaABCR mutant compared with USA300 LAC 
strain (Fig. 4.5A).  
Further, to examine MsaB regulation of ccpE and gudB, we performed an 
electrophoretic mobility shift assay (EMSA), which showed MsaB binding to the ccpE 
promoter (Fig. 4.5B) and thereby suggested that MsaB regulates the TCA cycle via ccpE. 
This also confirms our previous finding of MsaB regulation of ccpE in the UAMS-1 
strain (99).  
However, the absence of binding to the promoter of gudB (Fig. 4.5C), suggests 
that its regulation by MsaB is indirect. All these observations lead us to conclude that 
MsaB directly regulates ccpE to control TCA cycle activity and that the increased energy 






Figure 4.5 Measurement of expression and MsaB binding to the ccpE and gudB 
(A) Fold change expression of ccpE in late exponential growth phase and gudB in the chemically defined 
medium (CDM) for the msaABCR mutant compared with the USA300 LAC strain, as measured by qRT-
PCR. (B) MsaB binds to the ccpE promoter. Increasing concentrations of MsaB–His protein were 
incubated with a biotin-labeled, 50-bp, dsDNA probe incorporating the promoter region of ccpE. The band 
shift is shown in lane 5, while the shift was reversed in a competition assay with a 100-fold greater 
concentration of unlabeled probe in lane 6. (C) MsaB does not bind to the promoter of gudB as evidenced 
by the absence of band shift. 
4.6 The msaABCR Operon Negatively Regulates the NADH Dehydrogenase (ndh2) 
and Controls the Expression of ETC Genes 
The activated TCA cycle generates large amounts of reduced dinucleotides, the 
oxidation of which requires the electron transport chain (ETC) (94, 112). The electrons 
entering into the ETC from NADH are transferred to menaquinone by the NADH 
dehydrogenase complex. A series of oxidation reactions in cytochrome oxidases finally 
produces water, while pumping of protons (H+) across the membrane produces pH and 
electrochemical gradients or membrane potential (Δψ). In S. aureus, the NADH 









































(qoxBCD) contribute to the generation of membrane potential (117-119). Likewise, the 
F1F0 ATPase (atpA) also contributes to the generation of PMF by pumping out protons 
upon ATP hydrolysis (71, 120). In the stationary growth phase, the TCA cycle is de-
repressed when amino acids are catabolized. Therefore, we measured the relative 
expression of genes involved in the ETC, including ndh2, qoxBCD, and atpA, in the test 
strains grown in CDM containing amino acids. The qRT-PCR results showed a 
significant increase (>2-fold) in expression of the ndh2, qoxBCD, and atpA genes in the 
msaABCR mutant compared with the USA300 LAC strain (Fig. 4.6A).  
A previous study reported that ndh2 is a major NADH: quinone oxidoreductase, 
disruption of which showed a large reduction (70%) in membrane potential compared 
with the wild type USA300 strain (118). Considering the importance of ndh2 in the 
generation of membrane potential, we sought to investigate its regulation by MsaB. We 
performed EMSA to examine the binding of MsaB to the promoter region of ndh2. The 
result showed MsaB binding to ssDNA upstream of the transcription initiation site for 
ndh2 (Fig. 4.6B). However, MsaB did not show binding to the same region when using 
dsDNA. This result suggests that MsaB regulates ndh2, either at the post-transcriptional 
level or as an RNA chaperone, as previously reported (105). Together, these observations 
suggest that msaABCR (MsaB) directly regulates NADH oxidation via negative 





Figure 4.6 Expression of genes of electron transport chain (ETC) and MsaB binding to 
ndh2 
(A) Expression of ETC genes (ndh2, qoxB, qoxC, qoxD and atpA) was measured by qRT-PCR of RNA 
samples isolated from cells grown overnight in chemically defined medium (CDM). The bar graph shows 
the fold change in expression of genes in the msaABCR mutant compared with the isogenic USA300 LAC 
strain. (B) EMSA showing MsaB binding to the promoter of ndh2. Increasing concentrations of MsaB were 
incubated with appropriate concentrations of ssDNA from the region upstream of the transcription initiation 
site for ndh2. The band shift was reduced in a competition assay with a 100-fold greater concentration of 
unlabeled ndh2 probe. 
4.7 The Membrane Potential Determines the Persister Formation in the Stationary- 
Phase S. aureus Cells Against Aminoglycoside Stress 
Since we observed upregulation of ETC genes in the msaABCR mutant, we 
measured the membrane potential of our strains via flow cytometry using the fluorescent 
membrane stain DiOC2 (3). The results showed higher membrane potential in the 




contribution of membrane potential in persister generation, we measured the persister 
fraction in the presence of the proton iono-phore CCCP, a known inhibitor of PMF 
generation that dissipates H+ ion gradients. As expected, in the presence of CCCP (> 0.1 
M), the persister fraction in the msaABCR mutant reverted to a level comparable to the 
USA300 LAC and complementation strains (Fig. 4.7.1B).  
Likewise, CCCP (10 M) treatment drastically reduced the membrane potential in 
both USA300 LAC and msaABCR mutant strains (Fig.4.7.1A). The requirement of 
membrane potential in persister killing is further supported by the results from the 
individual ndh2 and qoxB mutants. The ndh2 and qoxB mutants showed significantly 
reduced membrane potential accompanied by an increased persister fraction relative to 
the isogenic USA300 LAC strain (Fig. 4.7.1C, D). The atpA mutant also showed reduced 
membraned potential relative to USA300 LAC but was not statistically significant (Fig. 
4.7.1C). Additionally, atpA mutant did show increased persister fraction (Fig. 4.7.1D) 





Figure 4.7.1 Decreased membrane potential causes increased persister cells formation 
(A) Stationary-phase cells washed twice with PBS were incubated with 3, 3′-diethyloxacarbocyanine 
iodide (DiOC2(3)) for 30 min in room temperature. After incubation, the cells were subjected to flow 
cytometry. The data represents the ratio between channel F3 (red fluorescence) and F1 (green 
fluorescence), calculated with FlowJo software. (B) Stationary-phase cells pre-incubated for 30 min 
with different concentrations of CCCP were exposed to gentamicin (20 μg/ml). At 24 h post exposure, 
the cells were harvested, washed, and plated for CFU counting. (C) Measurement of membrane potential. 
(D) Persister fraction in the mutants of the ETC genes ndh2, qoxB, and atpA compared with the isogenic 
USA300 LAC strain in the presence of gentamicin (20 μg/ml). Data represents the log10 survival fraction 
for the average of three independent experiments. Error bars represent SEM. Statistical significance was 
determined using student’s unpaired t-test. *, P < 0.05; **, P < 0.001; ns, not significant. 
As we stated above, the stationary-phase msaABCR mutant did not exhibit a low-
persister phenotype in response to vancomycin or ciprofloxacin. Therefore, our 




general, at least in the stationary growth phase. Indeed, a previous study demonstrated 
that ATP does not determine a persister switch in stationary-phase S. aureus cells (71). 
To further investigate this question, we measured ATP concentration in the 
stationary-phase ndh2 mutant, which showed a similar level of ATP as the isogenic 
USA300 LAC strain (Fig. 4.7.2), providing further evidence that ATP does not play a 
deterministic role in persister generation during stationary growth, especially in the 
presence of aminoglycoside. 
 
Figure 4.7.2 Cellular ATP level in ndh2 mutant is comparable to that of USA300 LAC 
The ATP concentrations per CFU were measured in the stationary growth phase. The data represent the 
average of three ATP concentrations per CFU for each individual sample measured with two biological 
replicates. Error bars represent the SEM for three independent experiments. ns, statistically not significant. 
Taken together, these observations indicate that membrane potential is required 
for the aminoglycoside killing of persister cells in the stationary growth phase and that 
the msaABCR operon negatively regulates the generation of membrane potential, thereby 






4.8 Gentamicin Uptake is Higher in the msaABCR Mutant 
It is known that PMF is necessary for aminoglycoside uptake in bacterial cells, 
although the complete mechanism underlying this association is not clear (40, 121). 
Aminoglycoside uptake, in turn, is increased with enhanced membrane potential. 
Increased membrane potential as well as increased aminoglycoside killing of the 
msaABCR mutant then led us to examine gentamicin uptake in our test strains using the 
gentamicin :: Texas Red conjugate (Gen :: TR) method. Stationary-phase cells were 
incubated with Gen :: TR, and its uptake was measured by flow cytometry. The results 
showed higher gentamicin uptake in the msaABCR mutant than in the USA300 LAC 
strain (Figure 4.8).  
 
Figure 4.8 Measurement of gentamycin uptake 
The conjugation of gentamycin with Texas-Red fluorescent (Gen :: TR) in 30:1 molar ratio was made in 
anhydrous N, N-dimethylformamide. The mixture was gently rotated for 3 days at 4°C. The washed 
stationary-phase cells were incubated with Gen :: TR for 3 h at 37°C with continuous shaking. After 
incubation, cells were washed twice and re-suspended in 500 μl PBS and was measured in flow cytometry 
with excitation/emission maxima at ~595/615 nm. The median values for PE-A were measured using 
FlowJo software. The mean of median values for the three independent experiments were 3589 ± 538 for 




Together, these results suggest that deletion of msaABCR in S. aureus increases 
the membrane potential, which causes higher aminoglycoside uptake, leading to creased 
aminoglycoside tolerance.  
4.9 The msaABCR Operon Regulates the Genes Involved in Oxidative Stress 
Response 
On transcriptomic analysis, we identified that the deletion of the msaABCR 
operon in the USA300 LAC strain induced differential expression of more than 10 genes 
that are involved in resisting oxidative stress (36). To further confirm, we measured the 
expression of these genes by qRT-PCR (Table 4.9). In both the assays, among the 
downregulated genes, notably, were the carotenoid biosynthetic genes crtM and crtN, ohr 
(SAUSA300_0786), katA and membrane protein (SAUSA300_0374). In contrary, the 














Table 4.9 Fold change expression of oxidative stress responsive genes in the msaABCR 
mutant relative to wild type strains 
Genes (Locus ID) Functional name 
Fold Change in expression 
USA300 LAC UAMS-1 
crtM (SAUSA300_2499) Squalene desaturase -3.58±0.24 
-3.25±0.05 




OsmC/Ohr family protein 
gene 
-3.8 ± 0.58 -2.18±0.11 
katA(SAUSA300_1232) Catalase -2.38±0.48 -3.7±0.10 
sodA(SAUSA300_0135) Superoxide dismutase +2.98±0.25 +3.44±0.74 
Membrane protein 
(SAUSA300_0374) Putative membrane protein -3.2±0.15 -7.4±1.83 
ahpC(SAUSA300_0380) 
Alkylhydroperoxide 
reductase -1.01±0.28 -4.49±0.83 
trx (SAUSA300_0747) Thioredoxin -1.05±0.19 +1.8±0.70 
dps (SAUSA300_2092) General stress protein 20U -1.26±0.12 -1.28±0.14 
glutathione peroxidase 
(SAUSA300_1197) Glutathione peroxidase +1.28±0.41 -2.65±0.44 
uvrA (SAUSA300_0742) Excinuclease ABC subunit A -1.02±0.78 +2.43±0.37 
Values are represented as mean fold change ± standard error of the mean 
4.10 The msaABCR Mutant is More Susceptible to Oxidative Stress In Vitro 
The differential expression of oxidative stress resistance genes in the msaABCR 
mutant suggested a possible regulatory role of the msaABCR operon in S. aureus 
response against the oxidative stress. To study this, in vitro survival assays in the 
presence of inorganic H2O2, organic hydroperoxides such as tert-butyl hydroperoxide 
(tBOOH) and cumene hydroperoxide (CHP) were performed. Post exponentially grown 
cells of wild type USA300 LAC and UAMS-1 strains, an isogenic msaABCR deletion 
mutant, and their complementation cells were exposed to H2O2 for 1 h at 37°C. The 




msaABCR mutant cells (1-log-fold reduction compared to that of the wild type), with 
10% to 12% survival in wild type and 8% to 10% in complementation strains, while 
survival was ~ 0.5% for msaABCR mutant cells in both strain backgrounds (Fig. 4.10.1).  
 
Figure 4.10.1 Oxidative stress survival assays in the presence of H2O2 
S. aureus cells grown for 24 h were washed and normalized to OD
600 
nm of 0.1 in 1 ml phosphate buffer 




and were incubated for 1 h at 37°C. After incubation, catalase (2000 




.  Cells 
were diluted and plated for CFUs count. The survival percentage represents the percentage of initial CFUs 




exposure in1 h. The data represent the SEM of the results of at least three 
independent experiments. Student’s unpaired t-test was used to compare the results of wild types to the 
isogenic mutants. ***, P < 0.001. aFSmut-msaB, msaABCR complemented with frameshift mutated msaB.  
To examine the tolerance towards oxidative stress, we also tested the growth 
pattern of the msaABCR mutant in the presence of 25 mM H2O2 in the nutrient-rich TSB 
medium. We observed that the growth of USA300 LAC and complementation cells was 
halted for 5 h. After this tolerant phase, the wild type and complementation cells resumed 




msaABCR mutant was reduced gradually to below the limit of detection (100 CFU/ml), 
resulting in a clear culture (Fig. 4.10.2A, C).  
On the other hand, the growth of UAMS-1 and msaABCR mutant cells was 
reduced in the presence of 25 mM H2O2 compared to that of the unstressed cells after an 
overnight incubation, while such growth delay was not observed in complementation 
cells (Fig. 4.10.2B, D). To confirm whether the killing was by ROS production, we added 
50 mM thiourea, an ROS scavenger, to the msaABCR mutant cells after 10 min of H2O2 
treatment. In the presence of thiourea, they resumed growth similar to that under the 
H2O2-unstressed condition (Fig. 4.10.2E). These observations suggest that the msaABCR 






Figure 4.10.2 Growth of msaABCR mutant is severely disrupted in the presence of H2O2 
S. aureus cells grown for 24 h were normalized to an OD
600





and B) Growth was monitored by CFUs count at different time points as indicated. (C and D) Observation 




































































4.11 The Resistance Towards H2O2 is Mediated Through Staphyloxanthin (STX) 
Production by the msaABCR 
The carotenoid pigment is the membrane-bound orange red C30 triterpenoid STX, 
the biosynthesis of which is encoded by the genes within the operon containing 
crtOPQMN and aldH (37, 38). Previously, we showed that deletion of the msaABCR 
operon significantly reduced pigmentation in S. aureus (97). On trans-complementation 
of the msaABCR mutant with the native msaABCR operon, the STX level was completely 
restored. However, trans-complementation with the FSmut-msaB msaABCR operon did 
not restore STX production in the msaABCR mutant. In fact, the FSmut-msaB msaABCR 
operon showed a similar level of STX defect as the msaABCR operon mutant (Fig. 
4.11A, B). Furthermore, the trans-complemented FSmut-msaB msaABCR operon cells 
also showed similar susceptibility to H2O2 killing as msaABCR cells. Taken together, 
these observations indicate that the msaB gene and/or protein is responsible for the STX 
production that corresponds to H2O2 susceptibility in S. aureus.  
In addition to significant downregulation of the crtM and crtN genes, our 
proteomics results also revealed a decreased level of carotenoid protein in the USA300 
LAC msaABCR mutant. To further verify the importance of STX in ROS resistance in 
our strain background, the crtM mutant, which is devoid of pigment production, was 
exposed to H2O2 stress that showed increased susceptibility, comparable with that of 
msaABCR mutant cells (data not shown). All these findings indicate the importance of 
functional MsaB in resisting H2O2 killing, which is likely to be mediated through STX 





Figure 4.11 Measurement of STX 
(A) Standardized S. aureus cells in 10 ml TSB were grown for 36 h at 37° C with continuous shaking. Cells 
were harvested, washed with deionized water, and normalized to an OD600 of 10 in 1 ml. Then, STX was 
extracted using the methanol extraction method. The values are presented relative to the wild type 
normalized to 1. (B) The corresponding pictorial representation of pigmentation. The data represent the 
SEM of the results of four independent experiments. Student’s unpaired t-test was used to compare the 
results for wild type with that of the mutants. *, P < 0.05.  
4.12 MsaB is a Positive Transcriptional Regulator of the crtOPQMN Operon, which 
is Epistatic to Alternative Sigma Factor B (SigB) 
To investigate whether the MsaB regulation of the crtOPQMN operon is direct, 
we performed a ChIP assay using an MsaB antibody at the stationary growth phase, in 
which STX production is visible. The wild type and msaABCR mutant cells were grown 
to stationary growth phase, and crosslinking of MsaB to its target DNA promoters was 
facilitated by treating the cells with a final concentration of 10 mM sodium phosphate 




MsaB antibody. To confirm specificity, the msaABCR mutant cells were included as a 
negative control in each assay. In our previous study we demonstrated the existence of a 
consensus sequence including the TTGTTTAAA region upstream of the cap promoter for 
MsaB binding (102). The primers specific for the crtOPQMN operon promoter region 
comprising the consensus repeat target sequence of MsaB were designed and used to test 
the amplification. The binding activity of MsaB revealed via ChIP assay indeed confirms 
that MsaB is a direct regulator of the crtOPQMN operon (Fig. 4.12A). 
 
Figure 4.12 Chromatin immunoprecipitation (ChIP) assay 
ChIP using an anti-MsaB antibody was performed to determine MsaB binding to the promoter region of 
(A) crtOPQMN operon, (B) ohr gene, and (C) sarZ gene. Primers specific for the corresponding promoter 
regions were used to amplify DNA after immunoprecipitation of wild type USA300 LAC cells. msaABCR, 
the negative control, which is a whole-cell extract from the msaABCR deletion mutant with anti-MsaB 
antibody. + control, PCR amplification from genomic DNA of the wild type strain, LAC::Tn SigB, 
immunoprecipitated DNA isolated from a transposon mutant of sigB in the USA300 LAC strain. P, the 




Previous studies have shown sigB to be a positive transcriptional regulator of the 
crtMN operon (122, 123). Deletion of msaABCR downregulates the transcription of sigB 
by 3.2 and 2.31-fold in the USA300 LAC and UAMS-1 strain backgrounds, respectively 
(Table 4.12). To examine whether SigB affects the binding of MsaB to the crtOPQMN 
operon promoter, we employed a Chromatin Immunoprecipitation (ChIP) assay with a 
sigB transposon mutant of the USA300 LAC strain. Our result showed that MsaB does 
also bind to the crtOPQMN promoter in the absence of sigB (Fig. 4.12A).  
Table 4.12 Fold change in the expression of stress responsive regulators in the msaABCR 
mutant relative to wild type strains 
  Fold change in expression 
Genes (Locus ID) USA300 LAC  UAMS-1 
sigB (SAUSA300_2025) –3.29±0.12 –2.31±0.14 
ssrA (SAUSA300_ 0766) +2.21±0.08 +10.83±0.19 
sarZ (SAUSA300_2331) +2.65±0.05 +3.39±0.18 
Values are represented as mean fold change ± SEM of three independent experiments.  
However, in the absence of MsaB binding to the crtOPQMN operon alone was 
not sufficient to activate crtM/N expression and/or pigmentation. These results led us to 
conclude that both MsaB and SigB are required for crtOPQMN operon expression and/or 
pigmentation and that their regulation is mutually epistatic. We were then interested to 
see how msaB transcription was affected by sigB.  The sigB mutation resulted in 
upregulated msaB transcription by 9-fold, indicating that sigB is a repressor of msaB 
expression. These results indicate the interaction between MsaB and SigB and the 
mechanism of regulation of the crtOPQMN operon are indeed complex and need further 




4.13 MsaB Positively Regulates ohr to Resist the Oxidative Stress Generated in the 
Presence of Organic Hydroperoxides 
The ohr gene encodes a protein that confers resistance to organic hydroperoxide 
in different bacterial species, including E. coli, P. aeruginosa, X. campestris, and S. 
aureus (124-128).  Deletion of the msaABCR operon resulted in the repression of ohr 
transcripts. This result led us to speculate whether the mutant is more susceptible to the 
organic hydroperoxides. In the presence of organic hydroperoxides tBOOH and CHP, we 
observed a significantly decreased survival percentage of msaABCR mutant cells 
compared with those of wild type and complementation cells in both USA300 LAC and 
UAMS-1 strains (Fig. 4.13). We observed that ohr mutant cells have increased 
susceptibility to tBOOH- and CHP-induced oxidative stress that is comparable to 
msaABCR mutant cells (Fig. 4.13).  
To examine whether the altered sensitivity to organic peroxides in 
msaABCR mutant cells is due to repression of ohr, a plasmid for inducible expression 
of the ohr gene (msaABCR :: POhr) was constructed and then transformed into msaABCR 
mutant cells. Overexpression of the ohr gene in the msaABCR mutant cells increased 
resistance against tBOOH and CHP to a level comparable to wild type. These results 
suggest that response of MsaB to organic hydroperoxide stress is likely to be dependent 





Figure 4.13 Survival assay in the presence of organic hydroperoxides 
S. aureus cells grown for 16 h were harvested, washed and normalized in PBS to OD600 6.0 of all strains 
tested. Then, 10 μl of serially diluted cells (10-1 to 10-8) were dropped onto the TSA plates containing 5 
mM tBOOH (A and B) and 4 mM CHP (C). Plates were incubated 24 h for CFUs count. Graphs represent 
the percentage of survived CFUs. Error bars represent SEM of the results repeated three times. Student’s 





Besides, the positive binding results in these assays confirmed that MsaB directly 
regulates the ohr gene (Fig.4.12B). A previous study by Chen et al. (91) showed that 
SarZ is a multigene regulator (Mgr) homologue that negatively regulates the ohr gene in 
S. aureus strain Newman (91). Under stationary growth conditions, we observed that 
sarZ expression was upregulated by 2.65, and 3.39-fold in the msaABCR mutants of the 
USA300 LAC and UAMS-1 strains, respectively (Table 4.12).   
We then sought to determine whether MsaB also regulates sarZ expression. The 
positive binding activity observed in the ChIP assay indeed demonstrates that MsaB also 
regulates sarZ (Fig. 4.12C). The findings from this study thus led us to conclude that 
MsaB directly regulates the ohr as a transcriptional activator and sarZ as a transcriptional 
repressor.  
4.14 The msaABCR Operon is Crucial to Persist Inside the Host Immune Cells 
Since the deletion of the msaABCR led to the differential expression of oxidative 
stress responsive genes as well as reduced survival in the presence of H2O2 and organic 
hydroxides, we sought to examine whether these phenotypes are translated into decreased 
bacterial resistance against innate immune clearance in ex vivo systems including 
macrophages, neutrophils, and whole-blood cells that additionally contain 
complementing proteins. Post exponentially grown cultures of bacterial cells were 
incubated with macrophages (RAW 264.7 cells), freshly collected neutrophils, and 
heparinized whole-blood cells from volunteers. We observed that msaABCR mutant cells 
were significantly defective in intracellular survival within macrophages, human 




copy of the msaABCR operon restored their survival to a level comparable with that of 
the wild type in neutrophils and human blood and to lesser extent (~70% survival 
compared to wild type) in macrophages (Fig. 4.14). These results indicate that msaABCR 
is crucial for S. aureus survival intracellularly of the host immune systems, which 
produce ROS that are lethal to the pathogens. 
 
Figure 4.14 Ex vivo survival assay with macrophages, neutrophils and human whole-
blood cells 
(A) S. aureus cells with a multiplicity of infection (MOI) of 10 were incubated with macrophages 
(RAW264.7 cells) at 37℃ in the presence of CO2. (B) S. aureus cells were incubated with heparinized 
human whole blood and freshly isolated human neutrophils to measure their intracellular survival rates.  
Results with human blood and neutrophils for the UAMS-1 strain were reported in a previous study (102). 
The data represent the means of three independent experiments. Error bars represent the standard error 
(SE). Student’s unpaired t-test was used to compare the results from wild types and their isogenic 




CHAPTER V – DISCUSSION 
This study identifies the novel role of the msaABCR operon in antibiotic 
persistence as well as in stress response. Specifically, in dissecting the mechanism, we 
report (a) the regulatory role of msaABCR in persister cells development by modulating 
energy metabolism in S. aureus. And, (b) we demonstrate the msaABCR regulation of 
oxidative stress response in S. aureus.   
5.1 Persister Frequency Depended on Growth Phase and Antibiotics Used 
In persister assays, we observed different trajectories of killing curves and 
persister plateau dependent on growth phases and the antibiotics used. This is 
conceivable since the robustness of the persister population depend on the kind of 
antibiotic stress that lead to the generation of physiologically heterogeneous population 
in bacterial cells (40, 129). Exponentially grown msaABCR mutant formed significantly 
less persister cells in most of the antibiotic used, whereas, the biofilms of msaABCR 
showed pronounced defect in persister cells formation against all antibiotic stresses. 
Previously, we showed that the immature biofilm in the msaABCR mutant is mediated 
through the increased processing of major autolysin Atl, by excessive protease production 
which led to uncontrolled cell death (98). However, the contribution of protease 
production to decreased antibiotic tolerance remains to be elucidated. Nonetheless, we 
reasoned that the loosely connected weak biofilms of the msaABCR mutant would not be 
as favorable as the robust biofilms of wild type USA300 LAC for generation of 
extremely tolerant persister cells. Likewise, in the stationary state of growth, the 




little to no effect in other antibiotics used, suggesting antibiotic dependent specific 
mechanism of the msaABCR regulation of tolerance in S. aureus.  
In a growing population, the frequency of persister cells depends on reduced 
expression of TCA enzymes accompanied by low ATP levels (65, 72). Although the 
msaABCR mutant exhibited higher ATP levels, the persister fraction in late exponential- 
phase varied among the antibiotic classes. For instance, gentamicin eradicated msaABCR 
mutant cells within 48 h. By contrast, a high persister fraction (~10%) was observed in 
the presence of ciprofloxacin for more than 4 days, whereas a persister fraction was 
observed to a lesser extent (~0.001%) in the presence of vancomycin. While it is not a 
unique observation that the efficiency of bactericidal antibiotics depends on the energy 
state of cells, the persister phenomenon seems to depend on how the bacterium responds 
to a stress in general. In support of this speculation, a recent study has indeed 
demonstrated the formation of intracellular persister cells in response to an antibiotic 
stress that also displayed multiple stress responses in S. aureus (64).  
5.2 Cellular ATP Level is not the Deterministic Factor for Decreased Persister 
As we observed a drastic increase in antibiotic tolerance and reduced intracellular 
ATP levels, our findings confirmed that cellular energy is required for the killing 
efficiency of bactericidal antibiotics. However, besides ATP, other factors seem to 
contribute to antibiotic tolerance. These factors may vary, depending largely on the 
growth phase, which in turn determines whether persister cells are generated or 
maintained and whether the cells are active or not. For instance, due to slow growth, 




vancomycin, which kill actively growing cells. Since the msaABCR mutant has similar 
growth and yield as that of the USA300 LAC strain, the killing efficiency of vancomycin 
and ciprofloxacin does not appear to be influenced by ATP concentration, especially in 
the stationary-phase. By contrast, we reasoned that the increased energy state along with 
the presence of active targets contributes to increased killing of the msaABCR mutant by 
bactericidal antibiotics during late exponential growth phase. It is also possible that 
deletion of msaABCR reduces the stochastic events of reduced TCA enzyme expression 
during exponential growth phase, resulting in a decreased persister fraction. On the other 
hand, the fact that stationary-phase msaABCR mutant cells are eradicated only by 
aminoglycosides suggests a different mechanism of persister killing.  
5.3 Membrane Potential Associates with Persister Fraction Against Aminoglycoside 
Stress  
Studies have shown a causal link between persister formation and membrane 
potential, primarily in the presence of aminoglycosides. A decreased persister fraction 
was observed in response to enhanced membrane potential and subsequently increased 
aminoglycoside uptake (40, 130, 131). Likewise, reduced membrane potential was shown 
to cause an increased persister fraction in the TCA mutants of S. aureus (71). The SCVs 
of S. aureus were also found to display increased resistance towards aminoglycosides due 
to low membrane potential (132). Likewise, disruption of serine biosynthesis (serA) with 
subsequently increased PMF led to a decreased persister frequency in E. coli (131). A 
recent study showed increased antibiotic tolerance associated with reduced ATP and 




of clues, the complete mechanism linking persister formation and membrane potential is 
not understood.  
According to our observations, it appears that the contributions of the energy state 
and membrane potential in antibiotic tolerance depend largely on the nature of the 
antibiotic stress. Nonetheless, we conclude that deletion of msaABCR induces S. aureus 
cells to transition to a higher energy state, causing decreased persister cell formation 
during exponential growth, irrespective of the antibiotics used. Whereas, due to higher 
membrane potential, stationary-phase msaABCR mutant cells failed to form persister 
cells, especially in response to aminoglycoside antibiotics.  
5.4 The msaABCR Operon Could be a Therapeutic Target for Persistent Infections 
Considering the urgent clinical relevance of persister cells, understanding the 
possible mechanisms of their eradication is highly important in selecting a therapeutic 
target. S. aureus systemic infections those are mainly associated with biofilms, which are 
difficult to treat. So far, eradication of persisters by aminoglycosides has been achieved 
in conjunction with the metabolites mannitol and fructose, by an ATP-independent 
acyldepsipeptide antibiotic (ADEP4), by drugs in combination with reactive oxygen 
species, and by membrane disruption-mediated clearance in different bacterial systems 
(33, 39, 40, 133, 134). However, there has been a lack of clinical efficacy for these 
strategies. On the other hand, the use of traditional antibiotics would be beneficial, 
considering the requirement of exhaustive clinical trials for novel therapeutics.  
Administration of gentamicin to treat S. aureus infections is widely used in 




skin infections with gentamicin without any adverse side effects (135, 136). Similarly, 
treatment with gentamicin was shown to control α-toxin production (137). Likewise, 
gentamicin was found to shorten treatment duration when prescribed in combination with 
daptomycin and vancomycin (138). All these results suggest that gentamicin is a potential 
antibiotic against S. aureus infections. However, increased evidence of treatment failures 
due to the presence of persister cells warrants identification of the factors influencing 
their formation. Our observations further indicate that msaABCR is a potential target to 
eradicate S. aureus persister cells, and it appears that the use of gentamicin in conjunction 
with a compound that inhibits msaABCR could be a successful therapeutic approach to 
treating recalcitrant S. aureus infections due to the presence of elusive persister cells. 
5.5 The Resistance Towards Oxidative Stress is Regulated via the msaABCR 
Modulation of STX Production 
In S. aureus, oxidative stress acts as a trigger for the expression of a multitude of 
responses (139, 140) that have evolved as complex regulatory systems in the pathogen to 
combat deleterious effects of environmental stimuli (74, 141). The carotenoid pigment 
STX is known to quench toxic singlet oxygen due to the presence of numerous 
conjugated double bonds (142-144). Studies have shown that mutants deficient in 
carotenoid production have increased susceptibility to in vitro oxidative stress, are more 
readily cleared by host immune cells (82, 141, 145, 146), and consequently demonstrate 
reduced virulence and survival in a murine model (145, 147, 148). Recently, a two-
component system, AirSR, was shown to transcriptionally regulate the crtOPQMN 




reduced crtM transcription in the msaB mutant. Although the putative DNA-binding sites 
for MsaB were predicted upstream of the promoter of the crtMN transcript (122) studies 
remained inconclusive whether MsaB mediates direct regulation of pigment production 
(105, 122, 149, 150). However, transcription of the crtOPQMN operon is shown to be 
positively regulated by the RsbUVW-SigmaB system (122, 150-152) and MsaB (122) 
and negatively regulated by small stable RNA A (ssrA) (153). In this study, we found that 
MsaB indeed directly binds the crtOPQMN operon confirming that it regulates the 
crtOPQMN transcripts. However, importantly, in the sigB mutant, the binding of MsaB to 
the crtOPQMN promoter was not regulatory, since the binding by MsaB does not appear 
to increase STX production in the absence of sigB. These observations indicate that 
transcriptional regulation of the crtOPQMN operon by the two regulators MsaB and SigB 
is rather complex, which needs to be further defined. Moreover, a recent study by 
Caballero et al. (105) showed MsaB binding to rsbVWsigB mRNA as a RNA chaperone, 
indicating the role of MsaB in sigB regulation (105).  
Consistent with the previous study, we observed a lower level of STX production 
in the sigB mutant than in the msaABCR mutant (122). Interestingly, in agreement with a 
previous report (150), the sigB mutant demonstrated no sensitivity toward H2O2 
compared with that of the isogenic wild type strain. These observations indicate that 
although SigB and MsaB are both required for STX production, the resistance to 
oxidative stress that is mediated through pigmentation is dependent on msaABCR operon 
regulation. Liu et al. (153) showed the involvement of ssrA RNA as a negative regulator 




aureus (153). In msaABCR deletion mutants, transcripts of ssrA are upregulated. 
However, it is unclear whether or how this effect is linked to crtOPQMN regulation by 
MsaB.  
5.6 The msaABCR Operon Regulates the Resistance Towards Organic 
Hydroperoxides via ohr 
Inactivation of osmC and ohr genes results in increased susceptibility toward 
intracellular killing by macrophages, which clear pathogens mainly by ROS-mediated 
killing (76, 154). The inactivation of OsmC and Ohr proteins in bacterial species was 
shown to be associated with increased susceptibility toward organic hydroperoxides, with 
little to no effect on H2O2 susceptibility (128, 155-158). The expression of Ohr is 
regulated by the organic hydroperoxide stress resistance regulator (OhrR) in different 
bacterial species (126, 127) In S. aureus, MgrA and SarZ have been considered paralogs 
of OhrR, functioning as a transcriptional regulator of Ohr (91, 140), which is mainly 
involved in sensing and resisting organic peroxide stresses. Chen et al. (91) identified 
SarZ as a functional homologue of MgrA, which acts as a global regulator for the 
expression of ~87 genes in S. aureus. In addition, the authors found SarZ to be a 
repressor of ohr, which was shown to be involved in resisting peroxide stress in S. aureus 
(91). SarZ represses not only ohr transcription but also msaABCR. Conversely, msaABCR 
activates both ohr and sarZ transcription. Recently, MsaB was shown to bind sarZ and 
mgrA mRNA as an RNA chaperon (105), suggesting their regulation by MsaB. All these 
results indicate the complex regulatory interplay among these regulators in sensing and 




Consistent with previous studies (128, 155-158), we found that inactivation of ohr 
resulted in hyper-susceptibility toward both organic hydroperoxides tBOOH and CHP, 
with little to no sensitivity toward H2O2 (data not shown). Furthermore, overexpression of 
the ohr gene in the msaABCR mutant increased resistance against tBOOH and CHP, 
suggesting that MsaB responds to organic hydroperoxide stress that is likely to depend on 
the ohr gene. However, we need further investigation into how MsaB senses peroxide 
stress and coordinates the expression of genes in response to oxidative stress stimuli.  
5.7 The msaABCR Operon is Crucial for Adaptation During S. aureus Infection 
We observed downregulation of katA and ahpC transcripts in msaABCR mutants 
in both the USA300 LAC and UAMS-1 strains. Of note, the katA and ahpC genes are 
required for survival, nasal colonization, and persistence of S. aureus via peroxide 
resistance (84). Reduced transcription of katA and ahpC in the msaABCR mutant 
indicates the possibility that the msaABCR mutant could also be less persistent under in 
vivo conditions. This speculation is corroborated by our findings showing that msaABCR 
mutants are highly susceptible to clearance by host immune cells. 
S. aureus has been reported to be a major intracellular persisting pathogen in 
chronic and recurrent infections (33, 159). Richards et al. (160) reported the existence of 
S. aureus clinical isolates with unique immune evasion ability and increased levels of 
stress-response proteins, including cold shock protein CspA, in persistent bacteremia 
cases (160). In addition to this study, several other studies also reported increased levels 




staphylococcal infections (160-162), highlighting their importance in stress response and 
their role in causing persistent S. aureus infections in the host.  
Oxidative stress triggers a multitude of responses in bacterial pathogens. While 
these protective strategies are crucial for bacterial survival and persistence in response to 
various environmental stimuli, the inability to cope with these stresses leads to the rapid 
clearance of pathogens by host immune cells. Likewise, antibiotic-generated ROS have 
been discovered to be crucial molecules that enhance the bactericidal activity of drugs 
against antibiotic-tolerant persister cells (163), whereas tolerance to antibiotics has been 
suggested as depending on the cell’s protective strategies against lethal ROS (164, 165). 
All these observations show that the msaABCR operon is highly important to S. aureus, 
contributing to its ability to survive in diverse environments, an ability that facilitates the 





CHAPTER VI - CONCLUSION AND FUTURE DIRECTIONS  
6.1 Conclusion 
All the observations reported in this study lead us to conclude that the deletion of 
the msaABCR operon induces a metabolically hyperactive state in S. aureus cells, as 
shown by higher TCA cycle activity and higher ATP content. This increased energy state 
of the msaABCR mutant leads to decreased persister formation in the presence of 
different classes of antibiotics in the late exponential growth phase. In stationary-phase, 
however, deletion of the msaABCR operon causes increased membrane potential in S. 
aureus cells, which makes a significant contribution to the abrogation of tolerance, 
specifically towards aminoglycosides. Based on the observations reported in this study, 
we propose a mechanistic model of msaABCR regulation of TCA cycle activity and 
NADH oxidation in USA300 LAC cells (Fig. 6.1.1). The msaABCR operon (MsaB) 
directly represses ccpE and indirectly represses gudB to regulate TCA cycle activity and 
subsequent intracellular ATP levels in S. aureus cells. In addition, the msaABCR operon 
(MsaB) directly represses ndh2, a major NADH: quinone oxidoreductase to regulate the 











Figure 6.1.1 An Overview of msaABCR (MsaB) regulation of the energy metabolism 
Inactivation of msaABCR in S. aureus upregulates ccpE, which in turn positively regulates acnA 
expression.  The consequent increased activation of the TCA cycle results in increased ATP and NADH. 
Oxidation of NADH, in turn, increases the membrane potential. MsaB also controls the expression of the 
ETC gene ndh2 as an RNA chaperone. This process leads subsequently to the biosynthesis of ATP by the 
F0F1 ATPase in S. aureus.  
Additionally, this study highlights the importance of msaABCR in the survival of 
S. aureus in the presence of various environmental stimuli that mainly exert oxidative 




a complex regulatory network against resisting oxidative stress by S. aureus. The 
interplay between these regulators is depicted (Fig. 6.1.2).  
 
Figure 6.1.2 Regulatory map of oxidative stress defense system 
MsaB positively activates transcription of the STX biosynthetic operon crtOPQMN and ohr gene. In 
addition, MsaB also activates the expression of sigB, which is a positive transcriptional regulator of 
crtOPQMN expression, and the regulation of the two genes seems to be mutually epistatic. On the other 
hand, MsaB represses sarZ, which in turn also represses the ohr gene. The oxidative sensing pathway by 
MsaB and the expression of genes remains to be elucidated. At this time, although we do not know whether 
SigB and SarZ directly regulate MsaB, the increased transcription of msaB in the sarZ and sigB mutants 
indicates the possibility of interplay between these regulators and MsaB.  
All these observations show that the msaABCR operon is highly important to S. 
aureus, contributing to its ability to survive in diverse environments, an ability that 




msaABCR operon induces the persistence of S. aureus infections, these results underscore 
that the operon could be a potential antimicrobial target to overcome recalcitrant 
staphylococcal infections. 
6.2 Future Directions 
Our observations of in vitro studies suggest that the msaABCR operon is crucial 
for S. aureus adaptation in environmental stress during infection. However, msaABCR- 
modulation of expression of the genes for adaptive responses inside the host cells remains 
to be understood. Understanding the regulation of intracellular persistence including that 
inside the non-phagocytic cells (osteoblasts, endothelial cells) is essential to control the 
recurrent S. aureus infections. Indeed, this is the area which is largely unknown in S. 
aureus. Therefore, understanding how the msaABCR operon senses the environmental 
cues, directs the gene expression and facilitates the persistence of S. aureus intracellularly 





Table 4.13 Lists of primers and probes used in this study 
Primers (qRT-PCR)                                          Sequence (5’→ 3’ ends) 
gyrA F GCCGTCAGTCTTACCTGCTC 
gyrA R TTTGCATCCTTACGCACATC 
gyrB F GGTGCTGGGCAAATACAAGT 
gyrB R TCCCACACTAAATGGTGCAA 
crtM F AAGTATTTAGTATTGAAGCACAAC 
crtM R ACGTTCATGTAATGTATAGTTAGC 




ohr F CGTAAAGGACATGTTTATACTGATGA 
ohr R TGTAAATATTTTTCAGCTTCTTCTTG 
katA F TTTAGTAGGGAATAACACACCAGT 
katA R CTCATATTTGTTCTAGGATCTCGT 
sodA F ACTAGCGGATATGATTGCTAACTT 
sodA R ATTTCCCAGAATAATGAATGGTTA 
sodM F CTGTACCTTCTACTGCAGCATTTA 
sodM R TTAGAACCACATTTTGACAAAGAA 
Membrane protein F ATGTTTGGATTTATTGGAATGTTAAT 
Membrane protein R AAAATACCACCTGGGATATCTTTAC 







dps F AAAAGAATTGAATCAACAAGTAGC 
dps R AACGTGTAATGAGAAGAAGTTAGG 
Glutathione peroxide F CGTTATGCTAATTGTTAATACAGC 
Glutathione peroxide R ATTACAAACCCTTGATCTTTGTAT 
uvrA F ACACGTGAAATGATGAGTAAAT 
uvrA R CCACCTACATAAACAGATAACG 
sarZ F TTGTAGGTTTCTTTCATCTTTCTC 




Table 4.13 (continued)  
sigB F GAAGCTAAGTCTATCTCTTTATCGTGAA 
sigB R CAAGAAATCGTTAAAGGCTTTGGTTATA 
ssrA F ATCAAACAATAATTTCGCAGTA 
ssrA R   GCATATCCTATTAAGGTTGAATC 
gltA F AAATCGTTATGAAAGAGCAATG 
gltA R   GGATTAGGCTTAAGTGGTTCTT 
acnA F   ATAGTGTTGTAACACCTGAATTAT 
acnA R  CATATAGAGGTTGATCAGTTACAT 
icd F  ATTGCTGACATTTTCTTACAAC 
icd R AGCATCTGAAATATAGTCACCA 
sucA F   CAGATGACGTTGAAGCTACTAT 
sucA R CGACGATAACCTACTAAATCAA 
sucD F   TTGACTGAAGAAGGTATTGGTC 
sucD R  TTGACTGAAGAAGGTATTGGTC 
sdhA F  TGAAATTATGACAGCAAATGTAAC 
sdhA R   CAATATCTTCATAACGTTTCATCA 
sdhB F   TTCTATGGTTATCAATGGTCGT 
sdhB R   TAACTGGGAAAGTATTCATTGG 
fumC F  TCGAAGTAGTTTATGGTTTTGC 
fumC R  CGTATACAATGGCATCTTTCTT 
ndh2 F AAATATGGTGTGGATCAAAATA 
ndh2 R  TAACTGCGTGGTTAACTAATTC 
qoxB F  CTTAATAGCTATACAAATTTCAGG 
qoxB R  ATAAACTTCATAGTTGGTGTTTTA 
qoxC F   TACACATGTGGTATTGCTATTTACTA 
qoxC R CAAAGACTAAACCTAAAAGTAACGTA 
qoxD F GTTTACGTAACACTATACACGTCA 
qoxD R TGAACATTAATAATTGAAGTCCTG 
atpA F TAGAAAGAGCAGCAAAATTAAA 






Table 4.13 (continued) 
gudB F  AAGCATTGCATAAATTGGGATT 
gudB R CCATCATCCATTCGTACAGG 

























Primers for ChIP assay  
crtOPQMN-ChIP-F  CTAATGGTTATGCATCAGGAAGTAAC 
crtOPQMN-ChIP-R CTAAATTGAATCACTCTCAATCATACTGAC 







Table 4.13 (continued)  





msaABCR :: Pohr-F ATGTATTTTAAATTAGGATCCTATAAGT
ATGGCA 
msaABCR :: pohr-R ACGTTGAATTCTCTCTTTAAGTTAATGC
TAATCTA 









aRestriction sites are underlined, bEMSA; Electrophoretic mobility shift assay; 
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